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Multinucleated giant cells (MGC) are homotypic macrophage syncytia associated with
granulomas. Despite their correlation with pathology, MGC functional contributions to
inflammation are relatively unknown. The objective of this work was to gain an under­
standing of MGC phenotype. First, techniques were developed to better enable the study
of these cells in vitro. Second, inorganic particles known to cause inflammation were
observed to cause MGC formation in the lungs. Finally, the particle that resulted in the
highest macrophage fusion was used together with the in vitro system to compare MGC and
macrophage phenotype in response to stimulation. The results contribute to fundamental
MGC cell biology knowledge that is important toward developing approaches to control
the foreign body response and understanding the role of MGC in granulomatous disease.
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Multinucleated giant cell (MGC):
a homotypic macrophage syncytium
associated with granulomas.
This chapter provides an introduction to multinucleated giant cells (MGC) and the
macrophages from which they are formed. First, macrophage biology, developmental
origins, and functional classification will be described. Next, MGC will be introduced with
an overview ofmorphological identification, phenotype, and pathological associations. The
role of these cells in the foreign body response is discussed, particularly in response to
particulate exposures.
1.1 Macrophages
It is important to note that macrophage behavior in vivo cannot be fully explained by studies
in vitro. From all that has been learned, we know that the macrophage is a complex cell in a
very complex environment. The environment defines the cell, and themacrophage is altered
when the environment is perturbed either by a toxic exposure or by any manipulation to
study the tissue. Consequently, our best information always has room for error. In addition,
there is much that we do not know about the macrophage response to toxic exposures and
the macrophage’s role in pathogenesis.
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Macrophages are derived from bone marrow stem cells. The monoblasts mature to
promonocytes and then to monocytes. Monocytes remain in the bone marrow for a short
period and move into the circulatory systemwhere they remain for 36­104 h [1]. From there
monocytes enter the tissue and mature into macrophages. Once in the tissue, macrophages
are relatively long­lived cells with a lifetime in the order of months [2]. Maturation of
monocytes to macrophages is driven by a combination of at least three factors: (i) genetic
programming, (ii) growth factors/cytokines, and (iii) the environment of the tissue. The
extent of the effect of the environment on cell maturation is a recent area of research.
Current thought is that the environment, growth factors and cytokines all contribute to the
macrophage phenotype.
The term “big eater” was coined by Metchnikoff in 1892 to describe the phagocytic
function of the macrophage, which is still considered one of the most important functions
of the macrophage. This includes recognition and, if possible, degradation of foreign
material. The macrophage is well suited for this activity, as it possesses a large number
of receptors functionally linked to phagocytosis, such as immunoglobulin, complement,
and scavenger receptors. Since macrophages are relatively large cells, they can accom­
modate ingested material. Macrophages are mobile cells capable of responding to various
chemotactic factors. They can release superoxide anion and proteolytic enzymes to kill
and/or digest microbes, and can present digested peptide fragments with the major histo­
compatibility complex (MHC) to trigger an immune response [3–6]. Finally, they can
release various mediators to: (i) recruit additional phagocytic cells (polymorphonuclear
neutrophils, monocytes, and macrophages); (ii) stimulate maturation of phagocytic cells;
and (iii) modulate the function of other local cells to respond to the adverse condition.
A major function of macrophages is regulatory in nature, in that as a front­line immune
responder, it affects the subsequent nature of the response. Therefore, the nature, or
phenotype, of the macrophage can have a profound effect on the outcome of an immune
2
response. In the context of exposure to foreign material (i.e particles), the outcome is
dictated by the local macrophage content, which may be dominated by one or several
different subsets at any given time.
The termmacrophage has occasionally been used to describe monocytes and monocyte­
derived cells in culture. This is a misnomer that can create confusion. The termmacrophage
should be used to describe tissue mononuclear phagocytic cells, and monocytes should be
used to describe the circulating mononuclear precursor cells. Since mononuclear­derived
cells in vitromay not adequately describe the truemacrophage [7, 8] in part for the preceding
reasons, they should be clearly distinguished.
Blood monocytes are larger than lymphocytes, have a rounded shape and have a
nuclear/cytoplasmic ratio of approximately one. They often present with a bean­shaped
nucleus with considerable margination of heterochromatin. Macrophages are larger
cells, have many lamellapodia, many subsurface vacuoles and an irregularly indented
nucleus with little heterochromatin. Macrophages also have more rough endoplasmic
reticulum, coated vesicles, lysosomes, and microtubules than monocytes. The macrophage
nuclear/cytoplasmic volume ratio is less than one. Consequently, the cells are easily distin­
guished morphologically.
1.2 Developmental origins
Originally, tissue macrophages were thought to solely be derived from bone marrow stem
cells. In this process, pluripotent hematopoietic stem cells (HSC) in the bone marrow differ­
entiate into multiple precursors, one of which, the common myeloid progenitor, gives rise
to granulocytes and monocytes. A continuum of monocyte translocation from the circu­
lation and differentiation within the target tissue was considered the primary mechanism
responsible for replacement of resident tissue macrophages. New evidence reporting
resident tissue macrophages in multiple organ systems originating from the yolk sac during
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embryonic development has caused a paradigm shift in our understanding of macrophage
biology [9, 10]. Furthermore, macrophages have recently been shown to self­maintain
resident tissue populations by local proliferation [11]. A summary of macrophage origin
is shown in Fig. 1.
1.2.1 Bone marrow­derived
HSC derived macrophages remain an important contributor to immunity as well as
responses to toxic exposure. In the bone marrow, macrophage­dendritic progenitors mature
to committed monocyte progenitors and then to monocytes. Monocytes remain in the bone
marrow for a short period and move into the circulatory system where they remain for 36­
104 h [12]. Circulating monocytes, which constitute about 5­10% of circulating leukocytes,
were originally described by the surface expression of CD14 [13]. However, multiple
monocyte populations are currently described in humans and animals based on additional
surface marker expression and generally fall in to one of two categories: inflammatory
monocytes and resident monocytes [14]. From the circulation, monocytes enter tissue
and mature into macrophages. Specialized HSC­derived macrophages can be recruited to
tissues following infection or toxic exposure, where they play a critical role in the inflam­
matory and immune response.
1.2.2 Yolk sac­derived
Recent studies using Cre­loxP­based fate­mapping and parabiotic mice have shown that
HSC­derived macrophages contribute very little to maintaining resident tissue macrophage
populations during “steady state” homeostasis [15, 16]. During embryonic development,
hematopoiesis occurs in the yolk sac in two phases: the primitive stage, which is primarily
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Fig. 1. Macrophage origins. Primitive hematopoieses begins in the yolk sac blood
islands at approximately 18 days estimated gestational age, during which erythro­
myeloid progenitors (EMP) differentiate into macrophages [19]. EMP from yolk sac
and hematopoietic stem cells (HSC) from the aorta­gonad­mesonephros (AGM) region
colonize the fetal liver. Other embryonic hematopoietic sites may exist that are not shown
here, such as large arteries and the placenta. Early definitive hematopoiesis occurs in
the fetal liver, where HSC differentiate into monocytes. Monocytes differentiate into
macrophages as they move from blood into tissue. HSC from the fetal liver colonize
bone marrow, where hematopoiesis begins during approximately the 11th week [20] and
continues throughout adulthood. Several uniquemyeloid progenitor cell intermediates have
been identified, including common myeloid progenitors (CMP), granulocyte­macrophage
progenitors (GMP), macrophage­dendritic progenitors (MDP), and committed monocyte
progenitors (cMoP). Eventually, monocytes formed in the bone marrow exit into the
circulation. Monocytes differentiate into macrophages as they move from blood into
tissue. Relative populations of yolk sac­derived and HSC­derived macrophages in the
tissue vary depending on the organ system. Both macrophage types have the capacity
for self­replication, but their extent of replication varies with certain factors such as the
inflammatory environment.
Author’s own work; reprinted/adapted by permission from Elsevier. 15.07 ­ Inflammatory
Cells of the Lung: Macrophages by Forrest Jessop, Kevin L. Trout, Andrij Holian, and
Christopher Migliaccio 2018. https://doi.org/10.1016/B978­0­12­801238­3.95651­4.
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At mouse embryonic day 10 (E10), yolk sac hematopoietic progenitors cells colonize the
fetal liver, which then becomes a central hematopoietic tissue for all lineages [17, 18]. The
majority of adult tissue macrophages, for most tissues including the liver, brain, epidermis,
and lung originate from erythro­myeloid progenitors coming from the fetal liver and not
HSCs from the bone marrow. Resident adult tissue macrophages from fetal yolk sac
origin are considered more specialized to the physiological function of the organ. For
example, alveolar macrophages express high levels of pattern­recognition receptors and
scavenger receptors, and are more adapt to surveillance of the alveolar spaces, phago­
cytosis, and particle clearance. Furthermore, there is evidence that yolk sac derived tissue
macrophages maintain lung resident populations independent of factors that cause bone
marrow recruitment of monocytes such as CCR2 [15].
In support of the in situ proliferation mechanism, colony stimulating factors have been
reported to induce proliferation of macrophages in vitro [21, 22]. In addition, Bitterman et
al. [23] have shown that 0.5% of alveolar macrophages incorporate 3H­thymidine which
could increase under chronic inflammation. This is a low frequency event and therefore
difficult to capture at one time point. It may also vary in importance between humans
and animal models. There is evidence that under steady state conditions, pulmonary
macrophages self­renew without addition from circulating monocytes, and there is a slow
turn over rate (40­60% replacement in one year) [24, 25]. Some studies designed with
specific irradiation protocols further support the self­renewel hypothesis [26].
Maturation of monocytes to macrophages or progenitor resident macrophages to tissue
specific macrophages is driven by a combination of at least three factors: (i) genetic
programming, (ii) growth factors/cytokines, and (iii) the environment of the lung tissue.
Tissue macrophages adapt specialized functions based on the tissue of residence [27]. The
extent of the effect of the environment on cell maturation is not certain. It can be speculated,




Just a few decades ago macrophages were considered to have a relatively homogeneous
phenotype. Macrophages were defined as mediators and regulators of inflammation, and
that inflammation was generally considered to be Th1. This is characterized by a response
involving classic inflammatory mediators: IFN­γ, TNF­α, IL­6, and IL­1β. However,
recent research has determined that macrophages are subject to their environment and
macrophage functions are altered by the local mix of signaling factors. Macrophages
are now categorized based on phenotypes that are defined by the expression of surface
markers, intracellular pathways, and solublemediators.These categories are described using
an ‘M’ nomenclature system [28–32]. There is no general consensus on macrophage polar­
ization prior to induction of an inflammatory response. Original naming created the M1
and M2 macrophage subsets where the M1 was considered the Classic subset and the M2,
by default, the alternatively­activated. Over time more subsets were defined when the M2
was further divided to account for different phenotypes, mechanisms of activation, and
additional pathologies associated with atherosclerosis.
1.3.1 M1: classic
The “classical” nomenclature, labeled as the M1 subset, refers to the phenotype typically
associated with macrophages: inflammatory cytokines, Th1­association, and antigen­
presentation capability. This subset is most commonly generated with either IFN­γ or TLR­
agonists [30, 31] (Table 1). Recent reports identify GM­CSF stimulation as a partial M1
agonist, specifically through its ability to enhance antigen presentation and many other M1
macrophage functions [33].
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Table 1. Macrophage subsets. Common activating signals and markers for each
macrophage M­classification. This listing is not exhaustive.
Reprinted/adapted by permission from Springer Nature Customer Service Centre
GmbH: Springer. Macrophage and Multinucleated Giant Cell Classification by Kevin




The M1 subset has a pro­inflammatory phenotype. This manifests in both the types of
soluble mediators and surface proteins expressed upon activation. Ex vivo polarization of
alveolar macrophages with IFN­γ induced changes in approximately 41 genes, specifically
including increased expression of Toll Like Receptors andmultiple CXCL chemokines [36].
In addition to the classic cytokines of IFN­γ, TNF­α, IL­6, and IL­1β, the M1 has been
associated with production and release of IL­12p70, reactive oxygen species (ROS) and
nitric oxide (NO) [34, 35]. This subset has also been described to express both MHC II and
CD86 on the surface which are key for T lymphocyte activation (Table 1).
Disease associations
TheM1 subset has been found to increase renal cell damage [50], as well as increase disease
in the mdx mouse model of muscular dystrophy [58]. M1 is the dominant macrophage
phenotype in infection (acute and chronic), and is thought to play a critical role in granuloma
formation in tuberculosis [34]. In addition, the M1 has been described as the predominant
phenotype associated with non­malignant tumor­associated macrophages (TAM) [59, 60],
and aspects of the phenotype have been shown to prevent HIV­1 infection [61].
Interaction with particulates
In animal exposure models to particulates such as silica or nanomaterials, an initial Th1
response has been implicated in the pathology, specifically through IL­1 signaling [62, 63].
In addition, recent studies have described a role of M1 macrophages in the inflammatory
response to joint replacement wear debris [64–67]. The usage of replacement joints leads
to the generation of particulates that are categorized as wear products. Some have proposed




This subset was originally designated as the M2 or alternatively activated macrophage.
However, as more phenotypes were characterized this subset was given the nomenclature
of M2a and was described as being activated by the Th2­associated cytokines IL­4 and IL­
13 [29–31, 44, 68]. The dependence of this subset on Th2 immunity was confirmed by
studies using IL­4Rα null mice, where this protein is a key functional component of both
the IL­4 and IL­13 receptors [69].
Function/phenotype
The M2a subset has a Th2­promoting phenotype. The production of several soluble
mediators have been associated with the M2a phenotype and promoting of Th2 type of
inflammation. While IL­10 and IL­1ra are more associated with an anti­Th1 inflammation
type of activity, the release of Ym1/Chi3l3 has been found to induce Th2 responses [43].
In addition, the surface expression of CD206 is greatly increased in the M2a [44]. The
M2a are also associated with increased intracellular expression of Arg­1 and FIZZ1, both
of which had been a couple of the original markers used for identification of these cells [28,
70, 71] (Table 1).
Disease associations
Both M2a and M2c subsets have been found to increase type VI collagen and fibrosis in
an adipocyte model [72]. Furthermore, the M2a phenotype has also been associated with
pulmonary and renal fibrosis [50].
Interaction with particulates
Th2 immunity plays a well­accepted role in models of lung fibrosis. This is entirely
consistent with the observed function of M2a macrophages in fibrosis and the therapeutic
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rationale for targeting this subset. In studies comparing wild­type mice and IL­4Rα null
mice, a significant increase in the M2a in wild­type, corresponded with the development
of silica­induced pulmonary fibrosis. However, IL­4Rα null mice that lack the ability to
generate the M2a had a significant decrease in the pathology [69].
1.3.3 M2b: alternatively activated
This subset is generated by the presence of antibody­antigen complexes [30, 45, 73].
Because these are also a pro­inflammatory type of macrophage their activation is via FcγR
ligation in conjunction with a TLR signal.
Function/phenotype
The M2b subset has a pro­inflammatory phenotype that is similar to the M1. These
macrophages produce the classic inflammatory cytokines IL­1β, TNF­α, and IL­6 in
addition to the surface proteinsMHC II and CD86 [30, 74] (Table 1). Thesemarkers suggest
an ability and propensity to activate nearby immune cells either by contact or within the
vicinity. However, a key difference between the M2b and the M1 is the finding that M2b
also produces IL­10 [30, 74].
Disease associations
The M2b subset has been found to play a key role in the pathology in the murine model of
lupus, and shifting macrophages to the M2a phenotype was shown to alleviate the disease
[75]. M2b have also been found in circulation and peripheral tissues following severe burns,
supporting a systemic activity for this subset [76, 77].
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Interaction with particulates
Silicosis and asbestosis have been associated with autoimmune comorbidities, including
lupus, which involve TLR signling and FcyR ligation [78, 79]. Though there are no reports
on the M2b phenotype in particle exposure and associated disease, their involvement is
likely.
1.3.4 M2c: regulatory
This subset is generated by the presence of classic anti­inflammatory mediators: TGF­β,
IL­10, or glucocorticoids [51].
Function/phenotype
The M2c are categorized as regulatory, but have anti­inflammatory or immunosuppressive
activity. This subset is a good example of a macrophage being a product of its environment.
Because theM2c is activated/generated by known immunosuppressive mediators, it follows
that they possess the same qualities. They have been shown to produce TGF­β and IL­
10 [47–49]. In addition, surface expression of CD163 is associated with this subset [52]
(Table 1).
Disease associations
The M2c, or “anti­inflammatory,” subset has been shown to be induced by apoptotic cell
uptake and promote epithelial and vascular repair [46, 50], as well as play a modulating
role to the M1 activity in themdxmouse model [58]. Both M2a and M2c subsets have been
found to increase type VI collagen and fibrosis in an adipocyte model [72].
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Interaction with particulates
To date there have been no studies focused on the specific interaction between the
M2c macrophage subset and particulates. Because the phenotype is considered to have
regulatory activity, the potential role these cells could play in disease is evident. Some
groups have hypothesized (personal communications) that deletion of this subset would
result in a loss of regulation, which may be a key event in developing particle­induced
pathologies (i.e. nanomaterials, silica). In addition, the use of this subset as a type of
cellular therapy could be beneficial in chronic inflammatory pathologies induced by partic­
ulates.
1.3.5 M2d: tumor­associated
While the M1 subset is considered to have antitumor activity, the M2d subset are generated
by the local environment and associated with tumor growth [55]. The factors involved in
the generation of the M2d include IL­6, leukemia inhibitor factor (LIF), and M­CSF [53].
Function/phenotype
The general definition of the M2d/TAM subset is that it promotes the growth of tumors
[80]. It is thought that these cells possess an immunosuppressive phenotype [53, 55]. This
activity has been found to be antagonized by the M1 macrohages [54].
Disease associations
This subset is rare and is associated with tumors.
Interaction with particulates
While particles such as asbestos have been associated with cancer [56, 81], the link between
particulates and TAM is not clear. Especially with such cancers as lung or gastrointestinal
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tumors, where exposures to environmental particulates is relatively consistent, the role of
the M2d/TAM as a potential mediator in this process is ripe for investigation. In addition,
current research in oncology treatments has started focusing on the use of nanomaterials
[57, 82, 83]. The use of particulates to treat tumors could take advantage of the phagocytic
capacity of macrophages in a targeted therapy.
1.3.6 M4 and Mhem/Mox: atherosclerotic­associated
Macrophages and their contribution to atherosclerosis, as an inflammatory disease, has been
an area of interest in cardiovascular research [84–86]. There are two to three types of
macrophages that have recently been described in association with atherosclerosis: M4
and Mhem/Mox [87–89]. The M4 appear to be generated by activation with the chemokine
CXCL4 [88]. The atheroprotective macrophages are generated by the presence of either
heme (Mhem) or oxidized phospholipids (Mox) [87, 89].
Function/phenotype
The roles and functions of these subsets are areas of active research. While the M4 appears
to fall into a role of promoting atherosclerosis, it is the Mhem/Mox subset(s) that are
described as having atheroprotection activities. The M4 is a classical­type macrophage
that is proinflammatory and, therefore, promotes atherosclerotic pathology through this
mechanism. The protective activity of the Mhem/Mox subset(s) involves the stabilization
of plaques [89].
Disease associations
As described in the above section regarding the generation of these subsets, these cells are
associated with the environment that is responsible for their generation: atherosclerosis.
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Interaction with particulates
To date no studies have investigated, let alone linked, the activities of these subsets
with particulate exposures and pathology. However, the association between particulate
exposure and cardiovascular disease has been shown [90], as has the effect of air pollution
particulates on macrophage functions [91, 92]. With the contradictory functions of these
subsets in the pathology, and the known influence of particulates on the disease progression,
it is a potential area of research to evaluate a possible connection.
1.4 Multinucleated giant cells
Cells with more than two nuclei within a common cytoplasm are described as multinu­
cleated or polykaryotic. Multinucleated cells formed by cell fusion are called syncytia,
while multinucleated cells formed by repeated mitoses without cytokinesis are called
coenocytes. Multinucleated cells are formed by cell­cell fusion in select human tissues
as part of normal physiological processes. These include the fusion of macrophages into
osteoclasts, myoblasts into myotubes, cytotrophoblast cells into syncytiotrophoblast, and
sperm with oocyte [93]. Additionally, recent discoveries suggest bone marrow stem cells
fuse with several cell types as a mechanism of tissue regeneration [94, 95].
Multinucleated giant cells (MGC) are typically defined as macrophage syncytia
associated with granulomas (Fig. 2). MGC are distinct from osteoclasts, which are
associated with bone and are present in normal, non­inflammatory conditions. The concept
that MGC are formed by macrophages fusing together is supported by fluorescent­ and
radio­labeling studies [96, 97]. This is in contrast to the mechanism of megakaryocyte
formation. Megakaryocytes become polyploid by endomitosis, resulting in a single






Fig. 2. Macrophage and MGC comparison. Photomicrographs (630x) of (A) human
alveolar macrophages, (B) human multinucleated giant cell, (C) mouse macrophages, and
(D) mouse multinucleated giant cell.
Experimental protocols were approved by the University of Montana Institutional Animal
Care and Use Committee, University of Montana Institutional Biosafety Committee, and
St. Patrick Hospital/Community Medical Center Institutional Review Board.
Author’s own work; Reprinted/adapted by permission from Elsevier. 15.07 ­ Inflammatory
Cells of the Lung: Macrophages by Forrest Jessop, Kevin L. Trout, Andrij Holian, and
Christopher Migliaccio 2018. https://doi.org/10.1016/B978­0­12­801238­3.95651­4
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Usage of the phrase “giant cell” is occasionally generalized to include cells of non­
monocytic origin that become multinucleated in certain pathological conditions (Table 2).
These giant cells are less commonly observed than giant cells of monocytic origin and are
not necessarily formed by cell fusion in association with granulomas. For the remainder
of this chapter, the phrase “multinucleated giant cell” (MGC) will refer to macrophage
syncytia associated with granulomas. These macrophage­derived MGC can be classified
as Langhans giant cells, foreign­body giant cells, and Touton giant cells.
1.4.1 MGC morphology
Multinucleated giant cells are classified into three morphological variants. Langhans giant
cells and foreign­body giant cells are the most common variants and are observed in a range
of granulomatous conditions. Touton giant cells are less common because they are usually
only observed lesions with high lipid content.
The eponym of the Langhans giant cell is Theodor Langhans, who was the first to
describe their unique nuclear arrangement in 1868 [99, 100]. The nuclei of Langhans giant
cells are arranged near the periphery of the cell in a circular pattern or in a semi­circular
pattern accumulating at one or two pole(s) of the cell (Fig. 3). Langhans giant cells usually
contain less than 20 nuclei and have a spherical or slightly ovoid shape with a diameter of
less than 50 μm. Langhans giant cells should not be confused with Langerhans cells and
Islets of Langerhans.
The nuclei of foreign­body giant cells are diffuse throughout the cytoplasm with no
well­defined spatial pattern (Fig. 3). Foreign­body giant cells may have a spherical or
irregular shape. The number of nuclei and cell size fluctuates greatly (Fig. 4), with some
cells containing over 100 nuclei and exceeding one mm in diameter.
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Aschoff cells are formed by fusion of Anitschkow cells (occasionally called caterpillar
cells), which are pathognomonic for rheumatic fever [102]. Anitschkow cells are
likely to be of macrophage origin, but a potential myocyte origin has been a source of
controversy [103, 104].
Balloon cells are pathognomonic for Type IIb focal cortical dysplasia (also called Taylor
dysplasia) and are found in subependymal giant cell astrocytomas, subependymal
nodules, and cortical tubers [105]. Balloon cell (not to be confused with multinu­
cleated melanocytes) origin is suggested to be neuronal or glial [106].
Floret giant cells have been observed in various neoplasms including multinu­
cleate cell angiohistiocytoma, pleomorphic lipoma, giant cell fibroblastoma, giant
cell collagenoma [107], neurofibroma [108], pleomorphic fibroma [109], and
dermatofibroma [110]. The name “floret” reflects the unique nuclear arrangement
around the periphery of the cell, similar to petals on a flower. Although fibroblast or
dendritic cell origins have been suggested [108], floret giant cell etiology is unknown.
Multinucleated epithelial giant cells are most often observed adjacent to the epithelial
surface or lumen in pathological conditions of the epidermis, gastrointestinal tract,
vulva, epididymis, and lungs [111–113].
Multinucleated erythroblasts are pathognomonic for congenital dyserythropoietic
anemia III and may be formed by incomplete cytokinesis of proerythroblasts [114].
Multinucleated fibroblasts were recently discovered in vitro to form as either syncytia
or coenocytes, depending on whether the culture contained cell lines or primary
fibroblasts, respectively [115].
Multinucleated hepatocytes are found in neonatal giant cell hepatitis and autoimmune
hepatitis [116, 117].
Multinucleated melanocytes found in nevi and melanomas are described as having a
balloon appearance due to large vacuoles or a starburst appearance due to nuclear
arrangement in lentigo maligna [118, 119].
Reed­Sternberg cells are pathognomonic for Hodgkin’s lymphoma and are formed by
multinucleation of the B cell­derivedHodgkin cell [120]. They becomemultinucleated
by a unique mechanism: mitosis with incomplete cytokinesis followed by re­fusion of
daughter cells [121].
Warthin­Finkeldey cells associated with measles, HIV, and Kimura lymphadenopathies
are suggested to be derived from T cells [122] or dendritic cells [123].
Table 2. Other multinucleated cells. Miscellaneous cells that become multinucleated in
pathological conditions. These cells may not necessarily be of monocytic origin, associated
with granulomas, or formed by fusion.
Author’s own work; reprinted/adapted by permission from Springer Nature Customer
Service Centre GmbH: Springer. Macrophage andMultinucleated Giant Cell Classification
by Kevin L. Trout, Forrest Jessop, Christopher T. Migliaccio 2016. https://doi.org/10.1007/
978­4­431­55732­6_1.
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Langhans giant cell Foreign-body giant cell Indistinct classification
Fig. 3. MGC morphology. Two frequently observed morphological variants of MGC are
the Langhans giant cell (left column) and foreign­body giant cell (center column). MGC
with less distinct nuclear patterns (right column) can lead to subjectivity or uncertainty
when classifications are based upon morphology alone. Not shown is the less common
Touton giant cell. MGC were generated in vitro by IL­4 treatment of mouse bone marrow­
derived macrophages (see Chapter 2).
Author’s own work; Three panels (top left two and bottom right) were reprinted/adapted by
permission from Springer Nature Customer Service Centre GmbH: Springer. Macrophage
andMultinucleated Giant Cell Classification by Kevin L. Trout, Forrest Jessop, Christopher
T. Migliaccio 2016. https://doi.org/10.1007/978­4­431­55732­6_1.
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Fig. 4. MGC size. A relatively large MGC with >100 nuclei and >300 μm diameter. MGC




The eponym of the Touton giant cell is Karl Touton, who originally called them “xanthe­
lasmatic giant cells” in 1885 [100, 101]. The Touton giant cell size, number of nuclei, and
arrangement of nuclei is similar to that of Langhans giant cells, except the nuclei in Touton
giant cells are surrounded by a foamy cytoplasm. This suggests that these cells may be
formed by fusion of foam cells, which are lipid­laden macrophages.
The morphology­based classification of these variants can lead to uncertainty in their
identification, especially when MGC have relatively few nuclei or unclear patterns of
nuclear arrangement. This gray area is augmented because MGC are usually observed at
only one timepoint during the continuum of the multinucleation process. For example, it is
possible that Langhans giant cells are precursors to foreign­body giant cells, or vice versa.
1.4.2 Environment/generation
One of the environments in which MGC are generated is in granulomas surrounding
implanted medical devices or biomaterials. This particular environment provides a useful
model system to characterize the dynamics of MGC formation. MGC begin to form within
the first three days following biomaterial implantation in rodents, reach a peak population at
2­4 weeks, and slowly decrease in population until reaching a steady­state [124, 125]. The
relatively short lifespan of an individual MGC is estimated to be approximately one week,
at this point the MGC is thought to undergo apoptosis [126]. The MGC population at the
implant site is maintained by continuous recruitment and differentiation of monocytes from
the circulation until the foreign body has been degraded or removed [127]. These MGC
populations have been observed to persist beyond 15 years post­implantation [128].
Well­known stimulators of macrophage fusion into MGC include IL­4 [129], IL­13
[130], and IFN­γ [131]. In some in vitro models, MGC formation is increased when these
fusion stimulators are combined with macrophage maturation factors: GM­CSF, M­CSF,
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or IL­3. The macrophage maturation factors alone do not induce fusion [132, 133]. Stimu­
lation with IL­4 or IL­13 in vitro results predominantly in foreign­body giant cell formation,
while stimulation with IFNγ results predominantly in Langhans giant cell formation [134].
Other factors suggested to stimulate MGC formation include α­tocopherol (a form of
vitamin E) [135], calcitriol (1,25­dihydroxyvitamin D3) [136], phorbol 12­myristate 13­
acetate [137], and T­cell mitogenic plant lectins concanavalin A and phytohemagglutinin
[138].
Progress in MGC research within the previous two decades has begun to elucidate the
mechanism of macrophage fusion. An overview of this mechanism is provided here. For
a more comprehensive description of proteins and signaling pathways implicated in MGC
formation, excellent summaries have been published as book chapters [128, 139, 140] and
reviews [141, 142]. The mechanism of macrophage fusion into MGC can be divided into
three major steps [143]:
1. Competence. Fusion stimulating factors such as IL­4 increase macrophage
fusogenicity or “fusion­competency.” Programming into a fusion­competent state usually
involves endogenous or exogenous signals that increase transcription of key proteins such
as MMP9 [144], E­cadherin [145], dendritic cell­specific transmembrane protein (DC­
STAMP), and osteoclast stimulatory transmembrane protein (OC­STAMP) [146].
2. Commitment. The fusion­competent macrophage must migrate into proximity
with a fusion partner. A chemokine that induces this migration during MGC formation
is chemokine (C­C motif) ligand 2 (CCL2), also called monocyte chemoattractant protein 1
(MCP­1) [147]. Cell­cell and cell­substrate adhesion are part of macrophage commitment
to fusion. For example, engagement of β1 and β2 integrins regulates MGC formation[148].
3. Fusion. Finally, the membranes merge and the cell undergoes a series of cytoskeletal
rearrangements. As an example of a membrane merging event, ATP activation of purinergic
receptor P2X7 results in exposure of phosphatidylserine in the plasma membrane [149],
22
which is recognized by class B scavenger receptor CD36 in the fusion partner [150].
Cytoskeletal rearrangements are important during migration as well as post­fusion. A
known factor involved in actin polymerization and reorganization during MGC formation
is Rac1 [147].
1.4.3 Function/phenotype
Due to their macrophage origin, it is suspected that MGC share some of the same functions
as macrophages. Also, similarly to macrophages, it is likely that MGC possess hetero­
geneous phenotypes based upon tissue location, pathological association, and stimulating
factors (e.g., IL­4 versus IFNγ). Another factor that may affect MGC phenotype is the
cell maturation stage. This alteration of activity is evident in MGC capacity for phago­
cytosis. A MGC is capable of internalizing approximately the same number of particles as
a mononuclear macrophage [151, 152], but phagocytosis decreases as the number of MGC
nuclei increases [124, 153].
MGC can phagocytose larger particles than macrophages [145]. When a foreign body is
too large to be engulfed, MGC attempt to degrade them extracellularly. MGC form adhesive
structures called podosomes that are localized to the ventral cell periphery, forming a
compartment between the MGC and foreign body [154]. A degradative microenvironment
is formed within this sealed compartment, likely as a result of lysosomal exocytosis. This
microenvironment contains degradative enzymes, an acidic pH, and reactive oxygen species
generated predominantly by NADPH oxidase [142]. In the context of medical implants,
MGC can degrade biomaterials through a mechanism similar to osteoclast degradation of
bone [155]. Specific enzymes released by MGC that have been implicated in foreign body
degradation include MMP9 [144, 156] and cathepsin K [157]. It has been hypothesized that
this MGC degradative activity may eventually be down­modulated [128]. If this is the case,
it is possible that MGC may reach a inactive phase, during which their primary function is
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to protect the host by sequestering the foreign material or pathogen.
1.4.4 Disease associations
MGCaremost commonly associatedwith granulomas of diverse etiology (Table 3). Multin­
ucleated cells have also been described in giant cell tumor of bone and soft tissues; however,
these cells exhibit features more characteristic of osteoclasts [158, 159].
1.4.5 Interaction with particulates
The most well­known lung conditions associated with MGC include tuberculosis infection
[153] and sarcoidosis [97]. There is a growing body of studies that describeMGC formation
in response to particle inhalation. MGC are frequently observed in response to inhalation of
antigens that cause hypersensitivity pneumonitis [160, 161] and inhalation of other organic
materials such as amycobacteria and fungi (Table 3). Inhalation of inorganic particles is also
known to induce MGC formation. MGC have been observed in the lungs of rodents after
exposure to silica [162, 163], asbestos [162, 164], sepiolite nanoclay [163], silver nanowires
[165], or multi­walled carbon nanotubes [166]. Giant cell interstitial pneumonitis is a patho­
logical pattern of hardmetal lung disease that is characterized by the presence ofMGC [167,
168]. This interstitial lung disease is usually observed as a result of occupational exposure
tungsten carbide and cobalt alloys. Inhalation of other metals have also been reported to
induce formation of MGC, such as beryllium [169].
1.5 Research motivation
Macrophages function as a first­line agent of immunity by phagocytosis of foreign material
and generation/regulation of subsequent immune responses. Numerous macrophage
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Classification Disease or pathogenic material
Autoimmune/Idiopathic
Annular elastolytic giant cell granuloma, granuloma annulare [170]
Crohn’s disease, ulcerative colitis [171]
Langerhans cell histiocytosis [172]
Rheumatoid Disease [173]
Sarcoidosis [97]
Vasculitides (e.g. Giant Cell Arteritis [174])
Endogenous materials
Keratin [175]
Lipids [100], cholesterol crystals [176]
Monosodium urate crystals [177]
Exogenous materials
Engineered nanomaterials (e.g. Ag nanowires [165], carbon nanotubes [166])
Medical implants [178]
Metals (e.g. Al [179], Be [169], Zr [180], Co/WC alloys [181])
Minerals (e.g. asbestos [182], silica [182], talc [183])











Filariasis (e.g. dirofilariasis [192], onchocerciasis [193])
Leishmaniasis [194]
Schistosomiasis [195]
Table 3. MGC disease associations. Granulomatous conditions in which macrophage­
derived multinucleated giant cells are found. This list of example conditions is not
exhaustive.
Author’s own work; reprinted/adapted by permission from Springer Nature Customer
Service Centre GmbH: Springer. Macrophage andMultinucleated Giant Cell Classification
by Kevin L. Trout, Forrest Jessop, Christopher T. Migliaccio 2016. https://doi.org/10.1007/
978­4­431­55732­6_1.
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phenotypic subsets have been identified. However, less is know about MGC phenotype and
function. Although MGC association with granulomas has been known for many years,
determining whether or not they significantly contribute to formation of the granuloma
requires an increased understanding of their biology. Studies of MGC are frequently
conducted in the context of medical implants, but few have examined macrophage fusion
in response to inhaled particles.
In recent years, various molecular mediators of macrophage fusion have been described.
Interleukin (IL)­4 is a well­known inducer of MGC formation and is commonly used to
study macrophage fusion in vitro. However, culture conditions used for models of IL­4­
induced macrophage fusion vary widely among different laboratories. Developing repro­
ducible methods to study MGC will help to define MGC function and response to foreign
materials such as environmental or engineered particles. These methods will be used to test
the hypothesis that significant quantities of MGC can form in response to inhaled particles
and the MGC phenotype is unique from their macrophage precursors. The following
describes the specific aims of each chapter.
Chapter 2 aims to determine the effects of varying culture conditions on mouse
bone marrow­derived macrophage (BMdM) fusion into multinucleated giant cells (MGC).
Previous studies have used multiple different culture methods without systematic
comparison or justification. First, the efficiency and objectivity of morphological quantifi­
cation methods will be improved by developing methods using fluorescent nuclear and
plasma membrane stains with automated image segmentation. Then, the effects of varying
in vitro conditions will be assessed using a model of IL­4­induced fusion in BMdM from
C57Bl/6 mice. The following culture conditions will be examined: growth timeline,
cell seeding density, growth surface, and addition of granulocyte­macrophage colony­
stimulating factor (GM­CSF) or macrophage colony­stimulating factor (M­CSF). Finally,
the most effective method for enrichment of MGC populations from mixed cultures will be
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determined.
Chapter 3 aims to quantitatively compare MGC formation resulting from exposure to
a spectrum of environmental particles and engineered nanomaterials, both in vivo and in
vitro. The particles for these experiments are selected to represent a wide variety of micron­
and nano­sized particles of both environmental and anthropogenic origin. These particles
include crystalline silica, multiwalled carbon nanotubes, titanium nanobelts, and crocidolite
asbestos. C57Bl/6 mice will receive particles by oropharyngeal aspiration and cells will
be collected by lavage after seven days for differential counts. In vitro experiments will
be performed as described in Chapter 2, except with the addition of particles at the same
time as IL­4. The capacity for MGC to engulf particles will be determined by qualitative
cytological observations.
Chapter 4 aims to demonstrate that the phenotype of MGC are unique from their
macrophage precursors. An in vitro BMdM model of IL­4­induced fusion will be used
to establish mixed cultures of macrophages and mGC. These cells will be separated by
methods determined in Chapter 2, then purified macrophage and MGC populations will be
compared at baseline or when stimulated by addition of particles as described in Chapter 3.
A multiplex immunoassay will be used to determine macrophage and MGC secretion of
the following cytokines: Interferon (IFN)­γ, tumor necrosis factor (TNF)­α, IL­1β, IL­6,
IL­10, IL­13 and IL­33. Flow cytometry will be used to determine macrophage and MGC
expression of surface markers: cluster of differentiation (CD)11b, CD11c, F4/80, and major
histocompatibility complex (MHC) class II.
Overall, this research contributes to the standardization and replicability of methods to
studyMGC, quantitatively demonstrates MGC presence in response to particles in the lung,
and leads to a new understanding of the unique MGC phenotype. This fundamental cell
biology knowledge will help to develop methods to control the foreign body response and
provide insight into other granulomatous conditions in which the role of MGC is unclear.
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Chapter 2
Factors influencing multinucleated giant
cell formation in vitro
2.1 Abstract
Macrophages fuse together to form multinucleated giant cells (MGC) in granulomas
associated with various pathological conditions. Improved in vitro methods are required
to better enable investigations of MGC biology and potential contribution to disease. There
is a need for standardization of MGC quantification, purification of MGC populations,
and characterization of how cell culture variables influence MGC formation. This study
examined solutions to address these needs while providing context with other current and
alternative methods. Primary mouse bone marrow­derived macrophages were treated with
interleukin­4, a cytokine known to induce fusion intoMGC. This model was used to system­
atically assess the influence of cell stimulant timing, cell seeding density, colony stimu­
lating factors, and culture vessel type. Results indicated that MGC formation is greatly
impacted by alterations in certain culture variables. An assessment of previously published
research showed that these culture conditions varied widely between different laboratories,
which may explain inconsistencies in the literature. A particularly novel and unexpected
observation was that MGC formation appears to be greatly increased by silicone, which
is a component of a chamber slide system commonly used for MGC studies. The most
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successful quantification method was fluorescent staining with semi­automated morpho­
logical evaluation. The most successful enrichment method was microfiltration. Overall,
this study takes steps toward standardizing in vitro methods, enhancing replicability, and
guiding investigators attempting to culture, quantify, and enrich MGC.
2.2 Introduction
Multinucleated giant cells (MGC) are homotypic macrophage syncytia associated with
granulomas. Occasionally, other cell types that become multinucleated in pathological
conditions are referred to as giant cells (see Chapter 1); however, the focus of this study
is on multinucleated cells of monocyte/macrophage origin. These MGC are found in some
autoimmune or idiopathic conditions, but are most commonly formed as a result of exposure
to persistent foreign microorganisms or materials. Recent in vitro studies have led to many
new discoveries about MGC, such as their mechanism of formation [141]. However, many
of these studies are completed using a range of methods with little systematic comparison
or justification.
Investigators have observed fusion of monocyte/macrophage cells into MGC in vitro
using primary cells and cell lines from a variety of tissue sources and species. Species
include human [196], mouse [197–199], rat [198], rabbit [200], and pig [201]. Primary cells
include bone marrow­derived macrophages (BMdM) [197, 199], blood monocytes [196],
peritoneal macrophages [198, 200], alveolar macrophages [198, 200], splenic macrophages
[199], and microglia [201]. Cell lines include RAW264.7 [197], UG3 [202], and J774
[198]. While it is useful to make observations using a variety of model systems, results
can be difficult to compare. Cell lines present a unique challenge because multinucleation
due to rapid divisions of immortalized cells could lead to artifacts, though they may be
particularly useful for studying MGC in the context of cancer. The two most commonly
published in vitroMGCmodels are human monocytes and mouse BMdM. There are certain
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advantages to mouse BMdM: availability of transgenic models, replicability gained from
genetic and environmental interindividual similarity, ethical considerations, and ability to
obtain high yields of relatively pure monocyte/macrophage primary cell populations using
simple methods.
It is common for in vitro studies involving BMdM fusion into MGC to first use
macrophage colony­stimulating factor (M­CSF) for BM cell maturation, followed by
treatment with interleukin (IL)­4 to stimulate MGC formation. Osteoclasts have been
formed in vitro using similar methods, except that receptor activator of nuclear factor
kappa­B ligand (RANKL) is used instead of IL­4. IL­13 signaling has some overlap
with IL­4, and both cytokines each result in similar rates of MGC formation [130].
Monocytes/macrophages have also been stimulated to fuse into MGC in vitro by other
means: live microbes, microbial components, concanavalin A with/without interferon­γ
in older publications, genetic manipulations, and stimulating factors released from other
cells. Some researchers use co­stimulatory factors together with IL­4, the most common
of which is granulocyte­macrophage colony­stimulating factor (GM­CSF). One laboratory
group (Table 4, Kyriakides) reports quite high fusion with Fms­related tyrosine kinase
3 ligand (Flt3L) when delivered together with IL­4. GM­CSF and Flt3L are often used
to generate dendritic cells with phenotypes distinct from each other [203] and from M­
CSF­dependent macrophages [204, 205]. MGC are traditionally considered to be more
macrophage­like, but some suggest dendritic cells can also fuse [206–208]. Because these
cell types have many overlapping features, more studies are needed to examine phenotypes
as they relate to MGC.
Experimental models of IL­4­induced BMdM fusion vary widely in terms of in vitro
conditions, such as media composition, stimulant concentrations, culture timing, and cell
seeding density (Table 4). Another important variable is the cell growth surface. These
surfaces may include untreated polystyrene (PS), tissue culture­treated PS (TCPS), glass,
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(A) Overview and BM maturation





Aderem 1 DMEM 10 Yes 50 No 4
Gordon 5 αMEM,RPMI,OptiMEM 10 Yes 50* No 3­10
Keegan 2 αMEM 10 Yes 20 No 1­5
Kyriakides 6 IMDM 10­20 Yes 1.5 100 10**
Miyamoto 6 αMEM 10 No 50 No 2­3
Morrison 2 αMEM 10 Yes 30 No 2
Park 1 DMEM 10 No 10 No 7














Aderem Unspecified Unspecified 50 No 6 Ploidy >16n ploidy 8
Gordon 1.3­2.5 Permanox 100* ±GM 100 1­4 %Fusion >2 nuclei 0­64
Keegan Unspecified Glass 10 M 20 5 %Fusion >2 nuclei 46***
Kyriakides 2.6­5.3 Untreated PS 10 ±GM 10 3­7** %Fusion >2 nuclei 29­77
Miyamoto 1.6 Microplate 50 ±GM 50, other 2­10 MGC/well, /cm2 >3 nuclei 0.2­10
Morrison 0.15 Microplate 50 GM 50 4­8 MGC/view >3 nuclei N/A
Park Unspecified Permanox 25 No 7 MGC number >1 nucleus N/A
Table 4. Methods in literature. Assessment of culture variables during IL­4­induced
fusion of mouse BMdM into MGC. All studies used a two­part process: maturation of BM
cells using M­CSF (A), followed by fusion into MGC using IL­4 (B). Notes for specific
parameters are indicated by asterisks. *Stimulating proteins were occasionally sourced
from cell line supernatants rather than recombinant proteins. **Media was changed
periodically throughout culture period. ***%Fusion estimated from BALB/c mice rather
than C57Bl/6.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing
Multinucleated Giant Cell Formation In Vitro by Kevin L. Trout and Andrij Holian 2019.
https://doi.org/10.1016/j.imbio.2019.08.002.
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various biomaterials, or various coatings. MGC formation has been reported to be enhanced
on chamber slides made from Permanox™ plastic [96]. Also, a culture dish coating
of particular interest is Arginine­Glycine­Aspartate (RGD) [196], which is a tripeptide
sequence present in extracellular matrix proteins (e.g. fibronectin) that can coat implanted
foreign bodies and are bound by integrins for cell attachment.
One of the most widely used MGC quantification metrics is the percent fusion of MGC
defined morphologically, usually via microscopy, as containing three or more nuclei within
a common cytoplasm. Although binucleated cells could beMGCprecursors, they could also
arise from cells undergoing mitosis without yet completing cytokinesis, so binucleated cells
are often excluded from MGC calculations to avoid artifacts that may especially occur in
cell line or cancer studies. A fusion index is calculated by dividing the total number of nuclei
within MGC by the total nuclei in all cells within the field of view or sample, which can
then be converted to a percent. This normalized metric provides a meaningful number that
can be used for comparisons between multiple studies, while other limited relative metrics
(i.e. MGC number per field of view) only allow for comparisons within a single study.
The percent fusion metric is also more objective than semi­quantitative scoring. However,
counting all the nuclei can be tedious. High content imaging methods have recently been
described [209], but automated methods may require specialized equipment such as a laser
scanning cytometer and can be less accurate when it comes to distinguishing MGC from
clumped macrophages.
Enrichment of MGC from mixed cultures would allow for more effective analysis of
these cells. Cells with unique surface proteins can be targeted by antibodies for sorting
using methods such as magnetic­activated or fluorescence­activated cell sorting (MACS
or FACS). Certain surface proteins are upregulated in MGC (e.g. dendritic cell–specific
transmembrane protein [210]), but whether the magnitude of upregulation is sufficient
for effective sorting has not yet been determined. Due to the lack of MGC­specific
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markers, nuclear fluorescence has been used with flow cytometry to distinguish MGC
from macrophages [151, 211]. However, these methods may have undesired effects on
subsequent in vitro assays due to cell stress during handling and interference from stains
or antibodies. Manual isolation methods such as laser capture microdissection [212] or
picking with a micromanipulator [213, 214] are damaging to cells and are not feasible for
large scale experiments. Some investigators propose that a short incubation with trypsin or
other proteases allows mononucleated cells to be removed by washing while multinucleated
cells remain [215, 216], but this technique can result in low purity and artificially selects
for a phenotype of cells containing more adhesion proteins. Density gradient centrifugation
is suggested to result in partial purification of osteoclasts [217], so testing this method
for MGC separation would be valuable. Finally, a simple approach without the need for
stains is to sort based on size, which may be possible using differential centrifugation [218],
microfluidics, microfiltration [219], or light scatter signals from flow cytometry.
The objective of this study was to evaluate how these various in vitro conditions
influence IL­4­induced fusion of primary mouse BMdM into MGC, as well as improve
methods for MGC quantification and enrichment. Experimental variables were selected
which we hypothesized would have the greatest impact on MGC formation, including
treatment timeline, seeding density, CSF treatment, and growth surface. A quantifi­
cation method was developed using fluorescent staining for a semi­automated approach
to morphological evaluation using routine microscope equipment and freely available
software. Finally, enrichment methods which we expected to be most promising were tested
for sorting MGC based on size or density. Results will help guide investigators attempting
to study MGC, enhance replicability, and elucidate factors critical to MGC formation.
Furthermore, observations such as fusion kinetics or reactions to differentmaterials/surfaces




2.3.1 Analysis of methods in literature
Primary research involving IL­4­induced fusion of mouse BMdM into MGC was assessed.
Related published research methods were grouped according to articles sharing a common
author, as shown in each row of Table 4. The “Laboratory” column contains the last name
of this author, which is often the senior or corresponding author on the cited publication(s).
The articles examined include: Aderem [220], Gordon [96, 150, 219, 221, 222], Keegan
[145, 223], Kyriakides [144, 147, 197, 224–226], Miyamoto [199, 210, 227–230], Morrison
[231, 232], and Park [233]. Seeding density during the MGC formation step was calculated
to a universal unit of cells/cm2 where possible. The quantification methodmost widely used
in all MGC literature, including in vivo studies, is %fusion of MGC defined as containing
>2 nuclei. However, some BMdM publications deviated from this standard. Estimates of
%fusion were calculated using data graphs and/or representative images from these publi­
cations where possible. Accuracy of these estimates may vary depending on the amount of
information provided in the article.
2.3.2 Cell culture materials and methods
Cells were grown in a humidified, water jacketed incubator (Thermo Fisher Scientific,
Waltham, MA) at 37°C and 5% CO2. Sterile 0.2 μm filtered culture media consisted
of RPMI­1640 with 10% heat­inactivated fetal bovine serum (FBS), 25 mM HEPES, 2
mM L­glutamine, 1 mM sodium pyruvate, 100 I.U./mL penicillin, and 100 μg/mL strep­
tomycin (FBS: VWR Seradigm, Radnor, PA; all others: Corning subsidiary Mediatech,
Manassas, VA). Cells were suspended by using 0.05% trypsin with 0.53 mM EDTA in
HBSS (Corning) or Accutase® with 0.5 mM EDTA in Dulbecco’s PBS (BioLegend, San
Diego, CA), followed by physical dislodging of cells as necessary using a cell scraper or
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pipette action. When specified, cells were fixed by 4% paraformaldehyde in PBS for 10min
at room temperature. Treatment concentrations for all recombinant murine proteins was 30
ng/mL, includingM­CSF (R&DSystems,Minneapolis, MN), GM­CSF (PeproTech, Rocky
Hill, NJ), and IL­4 (R& D Systems). Centrifugations of cells in tubes were performed at
RCFavg 300 x g for 5min. Cytocentrifugations of cells onto slideswere performed at approx­
imately RCFavg 250 x g for 5 min. Cell counting was completed using a Beckman Coulter
(Indianapolis, IN) Z2 cell counter.
Permanox is a trademarked (Nalge Nunc International, Rochester, NY)
polymethylpentene (TPX RT18XB; Mitsui Chemicals, Tokyo, Japan) tissue culture­
treated growth surface. Permanox slides have a silicone gasket (MDX4­4210; Dow
Corning, Midland, MI) that connects removable natural polystyrene chamber walls.
Media working volumes per chamber or vessel were as follows: 8­chamber permanox
slides (Thermo Fisher) at 0.4 mL, 60x15mm permanox dishes (Thermo Fisher) at 5 mL,
8­chamber borosilicate glass slides with non­removable wells (Thermo Fisher) at 0.4 mL,
24­well PS or TCPS plates (Greiner Bio­One, Monroe, NC) at 0.5 mL, and T75 TCPS
flasks at 20 mL. Designated plates were coated with 5 μg/cm2 RGD protein polymer
(F5022; Sigma­Aldrich, St. Louis, MO) for 30 min, then washed twice with PBS and used
immediately.
2.3.3 Mice
Male and female C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) aged 9 to 20 weeks
were used for all experiments. Mice were housed in microisolator cages with ad libitum
access to food andwater in a specific­pathogen­free facilitymaintained at 22 ± 2°C, 30–40%
humidity, and 12­hour light/12­hour dark cycle. Mice were euthanized by intraperitoneal
injection of sodium pentobarbital followed by a secondary mechanical means of euthanasia
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prior to removal of rear legs for bone marrow isolation in a tissue culture hood. Experi­
mental protocols were approved by the University of Montana Institutional Animal Care
and Use Committee.
2.3.4 Multinucleated giant cell (MGC) culture
BMdM methods were similar to those previously used in our laboratory [69]. BM was
flushed from the tibiae and femora in a sterile environment, pooled, centrifuged, resus­
pended in media, and seeded at 4 x 105 cells/cm2 in a T75 flask. Cells were incubated
at 37°C overnight. Adherent stromal cells were discarded, and suspended macrophage
progenitor cells were collected. In culture timeline evaluation experiments, these suspended
progenitor cells were seeded at 6 x 105 cells/cm2 in Permanox slides with M­CSF until the
media was replaced with IL­4­containing media at varying time points (Fig. 6). In other
experiments after the timeline was optimized, suspended progenitor cells were added to
T75 flasks at 2 x 105 cells/cm2 with M­CSF for four days to mature into BMdM. Then,
mature BMdM were seeded at 9 x 105 cells/cm2 (established in Fig. 7) in specified culture
vessels with IL­4 for four days.
2.3.5 Staining and microscopy
Cells in initial experiments (Fig. 5, A and B) were stained using a method similar toWright­
Giemsa (PROTOCOL™ Hema 3™; Fisher Scientific, Kalamazoo, MI) by submerging
slides in a methanol­based fixative for 90 sec, “Solution I” for 120 sec, “Solution II” for 30
sec, and water for 90 sec. Cells in remaining experiments were stained with HCS Nucle­
arMask Blue followed by CellMask Orange Plasma Membrane according to manufacturer
(Thermo Fisher) recommendations. When necessary, FluorSave™ (Calbiochem, Milli­
poreSigma, Burlington, MA) medium was used to mount coverslips on slides. Images
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for MGC quantification were collected using a routine transmitted light and epifluo­
rescent Zeiss Axioskop upright microscope with AxioCamMR3 camera (Carl Zeiss, Jena,
Germany) at 200x magnification with DAPI and TRITC filters. At least five random,
independent (non­overlapping) images were acquired per sample chamber. Fluorescent
images used to illustrate differences among staining methods (Fig. 5, C and D) were
collected using an Olympus FluoView FV1000 IX81 confocal microscope.
2.3.6 Quantification
MGC were defined morphologically as containing three or more nuclei within a common
cytoplasm. The number of MGC nuclei were manually counted, while the total nuclei were
counted by an automated method developed in the freely available, open­source ImageJ
v1.51­1.52 software (https://imagej.nih.gov/ij/index.html) (Appendix A). The number of
nuclei within MGC was divided by total nuclei within all cells to calculate a fusion index
for each image field. Fusion indices of all image fields within a sample were combined into
a mean, then multiplied by 100 to be expressed as percent fusion.
2.3.7 Enrichment
Cultures of mature mouse BMdM treated with IL­4, as described above, contain a mixture
of MGC and macrophages. Separation of this cell mixture into purified populations was
attempted using three enrichment methods. First, the mixed cell suspension was layered
on sterile isotonic Percoll™ colloid (GE Healthcare, Uppsala, Sweden) diluted with cell
culture medium to densities of 1.02, 1.05, and 1.08 g/mL to form a discontinuous gradient.
The gradient was centrifuged at RCFavg 400 x g for 30 min in a swinging bucket rotor
with slow acceleration/deceleration. Fractions were collected with a sterile Pasteur pipette
at gradient interfaces for staining and analysis. Second, the mixture of cells was stained
with NuclearMask for measuring nuclear fluorescence, forward scatter (FSC), and side
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scatter (SSC) with an Attune NXT flow cytometer (Thermo Fisher). Third, the mixture
of cells was suspended in 2 mL media, transferred onto a pre­rinsed cell strainer (PluriS­
trainer by PluriSelect; Leipzig, Germany), and washed twice with 4 mL/wash into a tube.
Then, the strainer was inverted and washed twice with 4 mL/wash into a new tube. The
first tube contained cells that were small enough to pass through the sieve, while the other
tube contained larger cells that were blocked by the sieve. The number of MGC relative to
macrophages in each tube was assessed for various cell strainer sizes.
2.3.8 Statistics
Graphs display mean and standard error for n≥3 independent replicate mice in each
condition. M­CSF groups in culture timing experiments were analyzed by linear regression
to assist interpretation of MGC formation over time (Fig. 6). Effects of CSF on IL­4­
induced fusion was assessed by one­way ANOVA (Fig. 8). Fusion data from cell seeding
density (Fig. 7) and culture vessel (Fig. 9) experiments included some sample groups with a
normal underlying distribution and some groups with a nonsymmetric, bimodal distribution
due to the large number of zero values. This was confirmed by Shapiro­Wilk tests. This
violates assumptions of normality required by parametric methods and violates assumptions
that all sample distributions are approximately the same form required by the nonpara­
metric Kruskal­Wallis test. Therefore, a one­sample sign­test with one­sided alternative
was selected to determine whether % fusion of each group was significantly different from
zero. The Holm­Bonferroni correction was applied to p­values to counteract increased type
I error due to multiple comparisons. All analysis was completed in R v3.4.0 statistical




2.4.1 Analysis of methods in literature
Primary literature was systematically assessed to determine which culture variables may
have the most potential to influence IL­4­induced fusion of mouse BMdM into MGC
(Table 4). Most studies used BM from C57Bl/6 mice ranging in age from 4 (Keegan)
to 30 weeks (Gordon). Mouse sex, BM growth surface, and seeding density during the
BM maturation step were rarely reported. Methods for elimination of stromal cells widely
varied or were not reported. Determining correlations between culture variables and effects
on fusion was difficult because the methods were so widely varied. However, this literature
synthesis demonstrates the importance of investigating these variables because results show
a very broad range of % fusion outcomes.
2.4.2 Quantification method
Non­standard MGC quantification methods in the literature create challenges when
attempting to compare and evaluate results. The normalized andmost objectivemetric is the
percent fusion of macrophages intoMGC, which are defined morphologically as containing
three or more nuclei within a common cytoplasm. These cells are typically visualized using
brightfield microscopy with traditional histological stains, but manually counting nuclei to
calculate %fusion is tedious and impractical for larger scale studies. Faster, more automated
analysis methods are possible by segmenting, or partitioning, images into regions repre­
senting nuclei and cell borders. However, segmentation of these images was challenging
due to inconsistencies in staining quality (Fig. 5, A andB) that often resulted in poor contrast
and unclear distinctions between nuclei, cytoplasm, and cell borders. Also, MGC cytoplasm





Fig. 5. Quantification method. Comparison of staining methods for morphological
quantification of MGC. Brightfield images show cells stained with Hema 3, a method
similar to Wright­Giemsa. Pseudo­color fluorescent images show cells stained with
NuclearMask (green) and a second channel consisting of either differential interference
contrast (DIC) or CellMask Plasma Membrane stain. (A) Example of lower­quality
staining with adherent cells. (B) Example of higher­quality staining with cytocentrifuged
cells. (C) NuclearMask + DIC. (D) NuclearMask + CellMask. Scale bars 20 μm.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing
Multinucleated Giant Cell Formation In Vitro by Kevin L. Trout and Andrij Holian 2019.
https://doi.org/10.1016/j.imbio.2019.08.002.
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In an attempt to improve image segmentation based on nuclei, a fluorescent nuclear
stain was used together with differential interference contrast (DIC; Fig. 5C). This method
allowed for automated counting of nuclei, but cell borders in the DIC channel were
unclear in regions where other cells were within close proximity. Therefore, a plasma
membrane stain was added to improve visualization of cell outlines and more accurately
determine whether a particular nucleus was within a macrophage or MGC (Fig. 5D).
The resulting images were well­suited for semi­automated analysis with freely available
software (ImageJ) to calculate % fusion. Furthermore, this stain combination is compatible
with routine fluorescent microscopes, which promoted simple, rapid acquisition of images
in subsequent experiments.
2.4.3 Culture timing
Primary mouse bone marrow cells treated with macrophage colony­stimulating factor (M­
CSF) mature into bone marrow­derived macrophages (BMdM), which then fuse into MGC
when treated with interleukin­4 (IL­4). An evaluation of studies using this in vitro model
shows that various permutations of culture conditions can have a range of effects on
BMdM fusion outcomes (Table 4). In order to make a more systematic assessment of
these variables, we first compared cell stimulation timelines to determine kinetics of MGC
formation and effects of BMdM maturity on percent fusion.
As expected, BM cells that received M­CSF for only one day (x=1) were immature
compared to cells in extended cultures. The average total number of nuclei per image field
on the first day after IL­4 treatment was 157 for the x=1 group, while all other groups
were 286±19 (standard error). Although the total number of nuclei in this group remained
consistent throughout all IL­4 treatment durations (range 132 to 157), the rates of fusion
were highly variable (Fig. 6, x=1). This suggests MGC death, detachment, or splitting may
have been occurring. Many of these MGC had a morphology that was different from those
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generated frommature BMdM in vitro or theMGC that are typically observed in vivo. They
appeared in localized regions of the culture and often consisted of vast cytoplasm containing
clustered areas of packed nuclei.
More consistent MGC results were observed with mature BMdM (Fig. 6). In all cases,
at least two days with IL­4 was required for high levels ofMGC.A relatively early timepoint
with consistently high fusion (M­CSF for 4d, then IL­4 for 4d) was selected for subsequent
experiments. The shorter culture period allows for more rapid sequential experiments while
still having sufficient number of MGC and avoiding unexpected effects on primary cell
condition when they are maintained in culture for extended periods of time.
2.4.4 Cell seeding density
The next in vitro variable examined was mouse BMdM seeding density prior to IL­4­
induced fusion into MGC. High cell density resulted in high fusion, which peaked at 9 x 105
cells/cm2 (Fig. 7). Fusion was reduced in the highest seeding density, 12 x 105 cells/cm2.
This culture contained overlapping/clumping cells. Likely, MGC formation was reduced
due to the number of cells exceeding available space for attachment to the growth surface.
Therefore, the seeding density with consistently high fusion, 9 x 105 cells/cm2, was used
for subsequent experiments.
2.4.5 Colony stimulating factors
As in previous experiments, BM cells were differentiated M­CSF. Then, the BMdM were
treated with IL­4 alone or in combination with M­CSF or GM­CSF to examine the potential
influence on fusion into MGC. Results show that neither CSF significantly alters IL­4­
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Fig. 6. Effects of culture timing. Time­course examining fusion kinetics of immature and
mature BMdM. BM on Permanox slides were treated with M­CSF for x days until media
was replaced with IL­4­containing media. Then, groups of cells were fixed daily for 6
days to be analyzed for % fusion. Regression lines with y­intercepts set to zero had slopes
of 1.8, 1.2, 0.6, 1.8, 1.5, and 1.4 corresponding to groups x=1, 2, 3, 4, 5, and 6 (regression
not displayed on graphs). Higher slopes reflect fast and consistent increases in % fusion.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing
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Fig. 7. Effects of cell seeding density. BMdM were added to Permanox slides at the
specified seeding density and treated with IL­4. After four days, cells were analyzed for %
fusion. Samples with % fusion significantly greater than zero by one­sample sign­test are
shown as *p<0.05 and **p<0.01.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing
















Fig. 8. Effects of colony stimulating factor. BMdM were added to Permanox slides at 9
x 105 cells/cm2 and treated with IL­4 alone or in combination with M­CSF or GM­CSF.
After four days, cells were analyzed for % fusion. No significant effects were observed by
one­way ANOVA at p<0.05 level.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing




The final in vitro variable examined was the influence of common culture vessels on MGC
formation. IL­4­induced fusion was highest on Permanox chamber slides (Fig. 9A). MGC
were observed in small numbers on all other surfaces: glass, untreated polystyrene (PS)
plates, tissue culture­treated PS (TCPS) plates, and RGD­treated PS or TCPS.
Next, we investigated whether increased MGC formation on Permanox slides was a
result of the plastic surface (polymethylpentene) or another component of the chamber
slide system, particularly the silicone gasket used by the manufacturer to attach the media
chamber to the slide base. Cells cultured on intact Permanox slides containing gaskets were
compared to cells on round 60x15mm Permanox dishes that did not contain gaskets. As an
additional control, cells grown in PS wells were compared to cells in PS wells containing
pieces of gasket that were cut from disassembled Permanox chamber slides.
In both cases, significant MGC formation was only observed in the presence of the
silicone gasket (Fig. 9B). Similar results were observed in the presence of an alternative
piece of silicone (ring gasket from a cryogenic vial; data not shown). This shows that
presence of silicone in the culture has a greater influence onMGC formation than the growth
surface itself.
2.4.7 Enrichment
Exploratory experiments were completed to enrich MGC from mixed macrophage­MGC
cultures. A pre­formed, discontinuous density centrifugation did not provide distinct
separation between macrophages and MGC. This indicates that the buoyant densities of
these cells are similar, likely as a result of similar ratios of nuclei to cytoplasm. The similar
ratios suggest that cytoplasm is conserved during macrophage fusion. More extensive





































Fig. 9. Effects of culture vessel. BMdM were added to the specified culture vessels at 9
x 105 cells/cm2 and treated with IL­4. After four days, cells were analyzed for % fusion.
(A) Culture vessels included Permanox chamber slides, glass, untreated polystyrene (PS),
tissue culture­treated PS (TCPS), and RGD­treated PS or TCPS. The Permanox slides
are manufactured with chambers attached via silicone gasket, which was hypothesized to
be causing increased MGC formation. (B) Therefore, fusion was compared for cells on
Permanox dishes without gaskets, Permanox slides containing gaskets, PS wells without
gaskets, and PS wells containing gasket pieces cut from the slides. Samples with % fusion
significantly greater than zero by one­sample sign­test are shown as *p<0.05 and **p<0.01.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing




When cell nuclei were fluorescently stained for analysis by flow cytometry, the
cells could be distinguished into groups of mononucleated macrophages, binucleated
macrophages, and MGC. However, the stain may interfere with experiments requiring cells
to be cultured after sorting, so forward scatter (FSC) and side scatter (SSC) parameters were
considered as a potential stain­free method of discrimination. MGC tended toward slightly
higher FSC and SSC than macrophages, but the overlap in the populations would prevent
sufficient separation of highly pure MGC without losing many cells (Fig. 10).
The best enrichment was achieved using microfiltration. Sieve mesh sizes 10, 15, 20,
30, and 35 μm were tested. The enriched population from the 20 μm size had the highest
average purity (number of MGC divided by total cells), which was over 20­fold purer than
the average filtrate population. Enrichment efficiency would likely be further increased by
protocol optimization (i.e. adjusting filter washing procedures) or by using microfiltration
in combination with another purification method. This simple approach would be useful for
future studies, allowing MGC populations to be compared with macrophage control groups
derived from the same source culture while avoiding potential interference from cell stains
or cell stress due to extensive handling.
2.5 Discussion
This study shows IL­4­induced fusion into MGC in vitro is greatly impacted by alter­
ations in certain culture conditions. This was demonstrated by systematic assessment of
cell stimulant timing, cell seeding density, colony stimulating factors, and culture vessel
type. A particularly novel discovery is that MGC formation appears to be greatly increased
by silicone. MGC culture methods vary widely between different research laboratories,
creating challenges when critically comparing results in the literature. Another challenge
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Fig. 10. Flow cytometry. Cells stained with NuclearMask can be identified by
flow cytometry as mononucleated macrophages (fluorescent intensity ≈100K­225K),
binucleated macrophages (≈225K­325K), or MGC (>325K). Further binary subclassifi­
cation of MGC based on number of nuclei may be possible, but a large quantity of cells
would be required for accuracy. Dot plots show that side scatter (A) and forward scatter
(B) tend to increase with nuclear fluorescence. However, scatter alone would not be
sufficient to separate MGC from macrophages with high purity. Results concatenated from
n=3 true replicates.
Author’s own work; reprinted/adapted from Elsevier: Immunobiology. Factors Influencing
Multinucleated Giant Cell Formation In Vitro by Kevin L. Trout and Andrij Holian 2019.
https://doi.org/10.1016/j.imbio.2019.08.002.
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for researchers attempting to study MGC is the ability to obtain relatively pure populations
of these cells together with appropriate macrophage control populations. Solutions to this
enrichment problem were explored, with microfiltration emerging as a successful method.
Finally, this study was enabled by our improved quantification methods, which provided
the means for accurate and efficient analysis of MGC formation.
Morphological analysis to calculate %fusion using brightfield microscopy and tradi­
tional histological stains was less suitable for large scale studies, varied in accuracy with
stain quality, and became more subjective when cells are densely packed together. Image
segmentation was facilitated by using fluorescent nuclear and cell membrane stains, which
was more conducive to automation. Quantification could be completed using routine
laboratory microscopes and freely available image analysis software, such as ImageJ or
CellProfiler. This stain combination would be adaptable to high­throughput automation
as necessary. When attempting to distinguish MGC from clumped macrophages, a stain
specific for plasma membranes was more effective than stains that diffuse throughout
the entire cell. The CellMask plasma membrane stain usually yielded well­defined cell
outlines but is not compatible with experiments requiring permeabilization. Alternatives
may include lipid, cholesterol, protein, or other novel membrane stains [234].
BMdM cell maturity and culture density were important variables affecting fusion.
IL­4 treatment of more mature BMdM (at least four days with M­CSF) resulted in more
consistent MGC formation than immature BMdM. High cell seeding densities resulted in
high % fusion, which is in agreement with previous results by Moreno et al [145] and
follows logically with the idea that cells are more likely to fuse when less migration is
required to reach proximity. These culture parameters were used for subsequent exper­
iments. No significant difference in fusion was observed when mature BMdMwere treated
with IL­4 + M­CSF versus IL­4 + GM­CSF, which has also been shown by Yagi et al [199].
To our knowledge, our report is the first to compare fusion of mature BMdM treated with
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IL­4­only versus CSF co­treatment. No differences were observed, likely because BMwere
already sufficiently differentiated and cultured at a density optimal for MGC formation. If
IL­4 was added to immature BM at a lower culture density, we would hypothesize CSF co­
treatment to increase fusion as an indirect side effect of CSF­stimulated proliferation and
differentiation.
IL­4­induced fusion of BMdM grown on Permanox slides was over twice as high
compared to other culture dishes, including: PS, TCPS, glass, and RGD­modified
polystyrene. This was expected based on previous studies with mouse thioglycolate­elicited
peritoneal macrophages [96, 235]. However, previous reports have not included control
experiments to determine which component of the Permanox slide system causes increased
fusion. Surprisingly, we found that this occurred due to the presence of a silicone gasket
that attaches the media chamber to the slide, rather than the Permanox surface itself. Future
studies are needed to determine how cellular events related to macrophage fusion are
impacted by silicone. It is possible that culture medium composition or surface properties
are altered as a result of adsorption, leachables, or release of by­products from manufac­
turing or degradation. Clinically, MGC are commonly found surrounding breast implants
and in other silicone granulomas [236]. Understanding these mechanisms are important
because of the variety of implantable siliconemedical devices with prolonged tissue contact,
including those with applications in ophthalmology, otology, cardiology, gastroenterology,
orthopedics, and aesthetics.
Many of the culture variables found to be important during fusion of BMdM would
likely influence other in vitro MGC models as well. For example, we hypothesize that
treatment timing and seeding density would also affect fusion in human blood monocyte
cultures, which is another frequently published MGC model. Other variables such as CSF
treatment effects may differ, as these monocytes are often supplemented with autologous
serum instead of additional M­CSF stimulation [196]. It would be valuable to repeat
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methods used in this study with other cell models, particularly the experiments examining
effects of silicone on MGC formation. Additionally, other future investigations should
compare phenotype and function of MGC from various monocyte/macrophage sources,
including MGC that have formed in vivo. Standardization of in vitromethods will facilitate
these comparisons. However, isolating large quantities of MGC for ex vivo experiments
remains challenging, and different methods used to induce MGC formation in vivo may
result in diverse phenotypes.
Overall, this study demonstrates macrophage fusion is influenced bymany experimental
variables, which need to be considered to improve in vitro study replicability within a
laboratory or between different laboratories. It is important for authors to provide detailed
methods in publications, such as culture vessel type and cell seeding density. Including
an IL­4­only positive control is helpful for interlaboratory comparisons, reduction of false
negatives, and troubleshooting when% fusion is outside the typical range. Although we
have assessed many major factors affecting MGC formation, there are other possible
variables that could be influential. Some examples include hormone variability between
serum lots, serum source [237], stimulating factor source, endotoxin levels [227], microbial
contamination [238], and interindividual differences among organisms used for primary
cell collection. This study provides a step toward standardization of major parameters
influencing macrophage fusion, and we hope it will serve as a guide for new investigators
attempting to culture, quantify, and enrich MGC.
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Macrophage fusion caused by particle
exposure
3.1 Abstract
Background: Multinucleated giant cells (MGC) are formed by fusion of macrophages in
pathological conditions. These are often studied in the context of the foreign body response
to biomaterial implants, but MGC formation is rarely assessed in response to inorganic
particles in the lungs. Therefore, a major objective of this study was to quantitatively
compare in vivo macrophage fusion resulting from exposure to a spectrum of micron­ and
nano­sized particles from both environmental and engineered origin, including crystalline
silica, multiwalled carbon nanotubes, titanium nanobelts, and crocidolite asbestos.
Methods: Groups of C57Bl/6 mice were instilled with inorganic particles or PBS
control. Lung cells were collected by lavage after one week for cell differentials, quantifi­
cation of macrophage fusion, and microscopic observation of particle uptake.
Results: MGC were present in lungs of all mice exposed to particles; no MGC were
found in control mice. Asbestos exposure resulted in significant macrophage fusion, which
coincided with significantly increased total lavage cells and percent neutrophils. Micro­
scopic observations show particle internalization in MGC and a unique case of potential
heterotypic fusion of macrophages with neutrophils.
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Conclusion: MGC can form in the lungs of mice within a relatively short one­week
time period after particle exposure. Observations of particles within MGC warrants further
investigation of MGC involvement in inflammation and particle clearance. It is important
for inhalation toxicologists to be aware that MGC appear in sufficient numbers for quantifi­
cation, rather than appearing simply as a chance occurrence.
3.2 Introduction
Multinucleated giant cells (MGC) are macrophage syncytia associated with granulomas
in various tissues. In the lung, they are found in interstitial lung diseases caused by
unknown (idiopathic) reasons, infection, or inhaled substances (Chapter 1). One of these
inhaled substances is inorganic particles from environmental or occupational exposures.
Increased MGC have been observed in bronchoalveolar lavage from humans with pneumo­
coniosis after inhalation of asbestos [182, 239], silica [182], coal [182], and hard metals
[168, 240]. Among these small number of studies assessing MGC formation in response
to inorganic particle inhalation, some include only a limited number of case examples.
Other challenges with human studies are that they rely on environmental exposures with
uncontrolled doses, durations, confounding co­exposures (e.g. smoking), and other inter­
individual variabilities.
There have been thousands of lung toxicology studies using laboratory animals exposed
to environmental and anthropogenic inorganic particles, but the potential for these particles
to cause macrophage fusion into MGC is rarely assessed. We identified seven in vivo
studies that quantitatively assessed MGC formation in lungs in response to inorganic
particle exposure, all of which showed an increase in MGC. The particles of interest and
animals used in these studies are: amosite asbestos in rats [164, 241], chrysotile asbestos in
rats [242, 243], crocidolite asbestos in mice [162], multiwalled carbon nanotubes in mice
[244], ultrafine titanium dioxide in rats [163], and silica in mice [162] and rats [163]. The
55
chrysotile studies by Lemaire were the only to quantify MGC using fusion index, which is a
commonly usedmetric to normalizeMGC in relation tomacrophageswhile also considering
MGC size in terms of nuclei number (Chapter 2, [141]). Comparing relative effects of
different particles on MGC formation can be challenging due to nonstandard quantifi­
cation methods and varying experimental conditions (e.g. exposure timelines) between
studies. If lung exposure to certain inorganic particles causes MGC formation, a logical
next step is to determine whether MGC directly interact with the particles. Microscopic
images ofMGC containing particles has been used as evidence of phagocytosis in lung cells
from mice exposed to multiwalled carbon nanotubes [166, 245] and humans with occupa­
tional exposure to coal [182] or hard metals [240, 246]. To our knowledge, there are no
published reports containing images with discernable MGC uptake of asbestos, silica, or
other inorganic particles.
The objective of the current study is to demonstrate that significant numbers of
macrophages fuse into MGC in mouse lungs within a relatively short time (7 days) after
exposure to inorganic particles. Particles for these experiments were selected to represent
a wide variety of micron­ and nano­sized particles of both environmental and anthro­
pogenic origin. They include crystalline silica (SiO2), multiwalled carbon nanotubes
(CNT), titanium nanobelts (TNB), and crocidolite asbestos (Asb). Each particle type was
hypothesized to result in quantitatively different macrophage fusion rates. Particles were
observed to be engulfed by MGC, suggesting an active role in uptake. Finally, we present
a case of potential macrophage heterotypic fusion with neutrophils, a unique phenomenon




The particles for this study were selected to represent a wide variety of micron­ and nano­
sized particles of both environmental and anthropogenic origin. The selected particles have
been shown previously by our laboratory group to be pro­inflammatory in mice. SiO2,
CNT, and Asb particles were obtained from Pennsylvania Glass Sand Company (Pittsburgh,
PA), Sun Nano (Fremont, CA), and Research Triangle Institute (Research Triangle Park,
NC), respectively. SiO2 was washed in 1 M HCl as previously described [247]. TNB was
synthesized as previously described [248]. Particle characteristics are shown in Table 5,
including references for further detail. For illustration purposes, relative sizes are shown in
Fig. 11. Endotoxin levels were determined to be negligible by Limulus Amebocyte Lysate
assay (Cambrex, Walkersville, MD).
3.3.2 Particle suspension
Particles were prepared into homogenous dispersions in phosphate­buffered saline (PBS,
pH 7.4) immediately prior to each in vivo exposure. The following were added to
PBS for adequate dispersion of engineered nanomaterials (CNT and TNB): 5.5 mM D­
glucose, 0.6 mg/mL mouse serum albumin, and 0.01 mg/mL 1,2­dipalmitoyl­sn­glycero­3­
phosphocholine (Sigma­Aldrich, St. Louis, MO). This dispersion medium has previously
been shown to not significantly alter pulmonary responses compared to PBS alone [249].
TNB were suspended by mechanical stirring for one hour to avoid potential fracture by
sonication [250]. Remaining particles were sonicated for one minute with a 500W, 20 kHz
Qsonica Q500 (Newtown, CT) cup­horn system at 30
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Abbr Particle Identifier Shape Diameter(nm)
Length
(μm) Ref
SiO2 Crystalline silica MIN­U­SIL5 Sphere, Irregular 200 to 2500 N/A [251]
CNT Carbon nanotube FA21 Tube, Multiwall 27 5 to 15 [252]
TNB Titanium nanobelt NB­2 Long Belt, Anatase 10 x 200 7 [250]
Asb Crocidolite asbestos N/A Fiber, Amphibole 160 5 [253]
Table 5. Particle characteristics. Properties of particles used in this study.
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1 μm
Fig. 11. Particles to scale. Illustration depicting relative size of particles (left to right):
crystalline silica (SiO2), multiwalled carbon nanotube (CNT), titanium nanobelt (TNB),
and crocidolite asbestos (Asb).
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3.3.3 Mice
Male and female C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) aged 8 to 12 weeks
were used for all experiments. Mice were housed in microisolator cages with ad libitum
access to food and water in a specific­pathogen­free (SPF) facility maintained at 22 ± 2°C,
30–40% humidity, and 12­hour light/12­hour dark cycle. Euthanasia was performed by
intraperitoneal injection of sodium pentobarbital. Experimental protocols were approved
by the University of Montana Institutional Animal Care and Use Committee (IACUC).
3.3.4 In vivo experiments
Mice were anesthetized by isoflurane inhalation and exposed to 30 μl of particle suspension
or sterile PBS control by oropharyngeal aspiration. Doses were 1 mg/mouse for SiO2 or 50
μg/mouse for other particles. These doses were selected to induce similar ranges of inflam­
matory responses as observed during previous dose escalation experiments in our laboratory
and to enable comparisons with our existing published data [247, 254, 255]. Mice were
euthanized after 7 days and cells were collected by lung lavage with PBS. Cell counting was
completed using a Beckman Coulter (Indianapolis, IN) Z2 cell counter. Cytocentrifugation
of cells was performed at approximately RCFavg 250 x g for 5 min. Slides were stained
using a Hematek 2000 autostainer (Bayer Diagnostics, Dublin, Ireland) with a modified
Wright­Giemsa (PROTOCOL™; Fisher Scientific, Kalamazoo, MI).
3.3.5 Microscopy analysis
Differential cell counting was completed by manual morphological evaluation. Multinu­
cleated giant cells (MGC) were defined as containing three or more nuclei. Macrophage
fusion into MGC was quantified as previously described (Chapter 2) by counting MGC and
macrophage nuclei in at least five independent (non­overlapping), random 100x to 200x
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magnified image fields per treatment. MGC quantification results are expressed as percent
fusion by dividing the number of nuclei within MGC by the total macrophage and MGC
nuclei, then multiplying by 100. Images showing particle uptake were acquired using an
Axioskop microscope with AxioCamMR3 camera (Carl Zeiss, Jena, Germany). The image
of potential heterotypic cell fusion was acquired using an Eclipse E800 (Nikon, Melville,
NY) microscope with DP26 (Olympus, Waltham, MA) camera.
3.3.6 Statistics
Multiple comparisons of means from cell differential counts was completed by one­way
ANOVA followed by Tukey’s HSD test. The MGC % fusion dataset contained sample
groups with many zero values (e.g. in PBS group), violating ANOVA assumptions of
normality and homogeneity of variance. The nonparametric Kruskal­Wallis test was not
appropriate because the shape of each sample distribution was very different. Therefore,
a one­sample sign­test with one­sided alternative was selected to determine whether %
fusion of each treatment group was significantly different from zero. The Holm­Bonferroni
correction was applied to p­values to counteract increased type I error due to multiple
comparisons. Statistical significance was defined as a probability of type I error occurring
at less than 5%. Graphs display mean and standard error for n≥3 independent replicate mice
in each condition. All analysis was completed in R v3.4.0 statistical software.
3.4 Results
3.4.1 MGC in lavage
An objective was to determine whether macrophages fuse into MGC within a relatively
short, 7­day time period after exposure to inorganic particles. C57Bl/6 mice were instilled
with a representative selection of micron­ and nano­sized particles of both environmental
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and anthropogenic origin, including crystalline silica (SiO2), multiwalled carbon nanotubes
(CNT), titanium nanobelts (TNB), and crocidolite asbestos (Asb). As expected, MGC
were not found in the lung lavage when mice were not exposed to particles (Fig. 12;
PBS control). Measurable numbers of MGC appeared in all particle­treated mice. MGC
formation is quantified by % fusion, which reflects both MGC size and abundance relative
to macrophages. Asbestos exposure resulted in the higher number of MGC, with statis­
tically significant % fusion. (Fig. 12).
3.4.2 Cell differentials in lavage
Lavage cell differentials were evaluated 7 days after particle exposure in order to provide
a more complete assessment and explore potential correlations with MGC formation
(Fig. 13). The total number of cells per mouse was significantly higher in response to
asbestos exposure compared to control. This increase in total cells was largely attributed
to neutrophil influx. The percentage of neutrophils in the lavage from mice exposed to
asbestos was significantly increased compared to control. Lung cell differentials from mice
exposed to other particles had similar increasing trends in total cells and neutrophils, though
not statistically significant.
3.4.3 Particle uptake
MGC appeared to actively interact with particles in the lung. Larger particles and nanoma­
terial aggregates became visible in the interior of MGC cells at increased magnification
(630x) with careful adjustment of microscope focus. MGC were found to contain particles














Fig. 12. Fusion in vivo. Quantification of MGC in mouse lung lavage 7 days after in
vivo exposure to specified inorganic particles. The % fusion of asbestos­treated group was










































Fig. 13. Cell differential. (A) Lavage cell differentials and (B) % neutrophils in mouse
lung lavage 7 days after in vivo exposure to specified inorganic particles. The total cells per
mouse (x105) and % neutrophils of asbestos­treated group were significantly greater than






Fig. 14. Particle uptake. MGCobserved 7 days after in vivo exposure to particles specified
in image labels. Scale equal for all images, bar 20 μm.
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3.4.4 Possible heterotypic fusion
A unique cell was discovered in the lung lavage from a mouse exposed to asbestos. This
was a multinucleated cell containing nuclei from both macrophages and neutrophils within
a common cytoplasm (Fig. 15). No visible membranes surround the neutrophil nuclei,
suggesting this large cell was formed by heterotypic fusion rather than MGC engulfing
whole neutrophil cells. Other cells of this type may have been present in the lung lavage
from asbestos­treated mice, but they unfortunately could not be identified with confidence
due to less clear staining and overlapping clumps of nuclei.
3.5 Discussion
Particle and fiber toxicology publications often neglect to assess macrophage fusion into
MGC. However, this study shows that measurable numbers of MGC do appear in the lungs
of mice exposed to a variety of inorganic particles. MGC formation could be directly
compared in response to different particles because appropriate quantification methods
were used. Exposure to crocidolite asbestos resulted in the highest % fusion. The number
of MGC were not as exceedingly high as commonly observed in response to biomaterial
implants, but this is a difficult comparison when considering the relative size of implants
versus particles. It is noteworthy that MGC appeared within only a short, 7­day time period
following particle exposure. Additional studies are necessary to determine why asbestos
caused more macrophage fusion than other particles. This outcome could be a direct conse­
quence of particle physical properties, such as size or aspect ratio, or an indirect conse­
quence of asbestos influencing other inflammatory processes.
Macrophage fusion tended to correlate with neutrophil influx, which may provide
evidence toward beginning to understand the cause ofMGC formation in response to certain
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Fig. 15. Heterotypic fusion. Unique case of potential macrophage heterotypic fusion with
neutrophils. This cell was observed 7 days after in vivo exposure to asbestos. Scale bar 10
μm.
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particles. Similar factors that stimulate neutrophilia may also contribute to fusion, such as
cytokines and chemokines present in the inflammatory lung environment. An example
experiment to test the impact of soluble factors would be to prepare a cell­free super­
natant of lung lavage from mice exposed to asbestos, then add it to bone marrow­derived
macrophages in vitro to observe MGC formation.
An interesting case of potential heterotypic fusion of macrophages and neutrophils
was observed. Another publication [256] claimed that Burkholderia thailandensis caused
heterotypic fusion of RAW264.7 macrophage cell line with neutrophils from human blood
in vitro. It is unclear in these images whether it is a clump of cells or a common cytoplasm
is shared. It is also likely that bacteria cause fusion by a separate mechanism. To our
knowledge, our study shows the first case of macrophage and neutrophil fusion in vivo and
in response to inorganic particles. It is important to note that only one obvious cell of this
type was observed, so additional confirmatory studies would be important. Other cells types
have been considered for potential heterotypic fusion with macrophages as well, including
T lymphocytes in response to HIV­1 [257] and somatic cells in tumor pathogenesis [143].
Microscopic observations of particle uptake were evidence of MGC interaction with
particles in the lung after in vivo exposure to all types examined (SiO2, CNT, TNB, and
Asb). It is unknown whether phagocytosis occurred before or after macrophage fusion
into MGC; this would be challenging to assess in vivo. Researchers have hypothesized
that macrophages fuse as a result of attempting to phagocytose larger objects, which could
explain why larger particles such as asbestos cause more MGC formation. In vitro studies
using polystyrene beads have shown that MGC are capable of phagocytosis and can inter­
nalize larger particles than macrophages [145, 219, 258]. Additional studies are needed
to compare macrophage and MGC phagocytic capacity for various environmental and
engineered particles, as well as to compare expression of surface receptors related to phago­
cytosis.
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In conclusion, this study shows that MGC can form in the lung within only 7 days
after exposure to inorganic particles, with significant macrophage fusion after exposure to
asbestos. Asbestos also resulted in significant increases in total lavage cells and percent
neutrophils. Nano­ and micron­sized particles of both environmental and anthropogenic
origin were observed to be engulfed by MGC. Therefore, it is important for inhalation
toxicology researchers to be familiar with MGC in order to identify them while completing
routine cell differentials, as well as appropriately report quantification of fusion. Further
investigations are warranted to determine the role of MGC in the inflammatory response
and particle clearance.
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Chapter 4
Multinucleated giant cell phenotype in
response to stimulation
4.1 Abstract
Macrophages fuse into multinucleated giant cells (MGC) in many pathological conditions.
Despite MGC correlations with granulomas, their functional contribution to inflam­
mation is relatively unknown. An in vitro mouse model of IL­4­induced bone marrow­
derived macrophage fusion and microfiltration were used to generate enriched MGC and
macrophage populations. Phenotypes were compared in response to well­known inflam­
matory stimuli, including lipopolysaccharide and crocidolite asbestos. Surface markers
were assessed by flow cytometry: CD11b, CD11c, F4/80, and MHC II. Secreted cytokines
were assessed by multiplex immunoassay: IFN­γ, IL­1β, IL­6, TNF­α, IL­10, IL­13, and
IL­33. Results show that MGC maintained macrophage surface protein expression but
lost the ability to produce a cytokine response. This suggests a potentially beneficial
role of MGC in isolating the host from a foreign body without contributing to excessive
inflammation. This study and future research using other stimulants and environments are
important to gaining a fundamental MGC cell biology understanding. This will inform
approaches to controlling the foreign body response to particle exposure, medical implants,
and many diseases associated with granulomas.
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4.2 Introduction
Macrophage fusion into multinucleated giant cells (MGC) occurs in pathological events
associated with granulomas. MGC most often form in response to persistent microor­
ganisms or materials, but are also found in certain autoimmune or idiopathic conditions
(Chapter 1). One example is medical implants, where MGC have been observed to persist
on the device for over 15 years post­implantation [128]. The well­established correlation
with granulomatous conditions may lead to the assumption that MGC actively contribute
to inflammation and fibrosis, but their physiological role remains unclear [259, 260]. A
better understanding of MGC functions in disease is important for future development of
therapeutics and approaches to control the foreign body response.
Phagocytosis and extracellular degradation of foreign material are among the fewMGC
functions that are more commonly described. Studies using mouse cells in vitro have shown
MGC can phagocytose larger polystyrene beads than macrophages [145, 219, 258]. Human
clinical [182, 240, 246] and mouse in vivo ([166, 245], Chapter 3) particle inhalation
toxicology studies have provided microscopic images of MGC with internalized coal,
hard metals, asbestos, silica, multiwalled carbon nanotubes, and titanium dioxide nanopar­
ticles. When macrophages encounter foreign bodies too large to be engulfed, it is hypoth­
esized that they fuse into MGC to degrade or sequester them. Podosomes form a sealed
compartment that is filled by lysosome exocytosis with degradative enzymes, reactive
oxygen species, and an acidic pH (Chapter 1). This process, occasionally termed “frustrated
phagocytosis,” occurs in MGC and osteoclasts [232, 261]. Similar to MGC, osteoclasts
are multinucleated cells formed by macrophage fusion. Osteoclasts are distinguished by
their presence in non­pathological conditions where they function to resorb bone and are
commonly identified by tartrate­resistant acid phosphatase (TRAP) expression. SomeMGC
express enzymes associated with degradation, including cathepsin K [157, 262] and matrix
metalloproteinase­9 [144, 156], but levels in osteoclasts are usually higher, coinciding with
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increased bone resorption capacity [261, 263]. It is possible that MGC degradative activity
is similar to macrophages during initial formation, then diminishes shortly afterwards [128,
264].
There is a lack of research describing phenotypic differences between MGC and the
macrophages from which they originate, especially in the context of their inflammatory
activity. In vivo and ex vivo studies on this topic are limited because MGC are difficult
to isolate in sufficient quantity and purity for successful analysis. Controlled in vitro
environments are favorable for investigating effects of specific treatments directly on the
cells and analyzing cells using a broader range of techniques (e.g. flow cytometry). The
most frequently published in vitro MGC models use interleukin (IL)­4 to stimulate MGC
formation from human blood monocytes or mouse bone marrow­derived macrophages
(BMdM). We have identified two studies that assess immune profile differences between
macrophage and MGC. Khan et al [263] compared macrophages, osteoclasts, and MGC
using mouse BMdM. Although the focus was on osteoclasts and related markers, CC
chemokine and CC receptor gene expression was also assessed. MGC expressed higher
CCL3, CCL4, CCL5, and CCL9 than macrophages, while others were generally similar
depending on timepoint. McNally and Anderson [265] compared macrophages and MGC
derived from human monocytes. Western blots of whole cell lysates and cell immunos­
taining were used to detect lymphocyte co­stimulatory, osteoclast, and dendritic cell related
markers. Results of interest include MGC displaying increased human leukocyte antigen
(HLA­DR), slightly increased CD11c, and loss of CD14. A common limitation of these
studies is that they do not control for confounding effects of IL­4 treatment. For example,
HLA­DR in MGC may not necessarily be increased as a result of multinucleation, rather
this is likely attributed the culture receiving IL­4, a known inducer of HLA­DR [266].
Questions remain about MGC phenotype and function. Ultimately, it is important to
knowwhether the presence of MGC in granulomatous conditions is beneficial or damaging.
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The answers would influence therapeutic approaches. The objective of this study was to
determine how the phenotype of MGC unique from their macrophage precursors in the
context of inflammation. This was investigated using our recently described model of
IL­4­induced fusion of mouse BMdM and techniques for MGC enrichment and analysis
(Chapter 2). Comparing enriched macrophages and MGC from the same original culture
controlled for confounding effects. Inflammatory response was assessed by stimulation
with conventional lipopolysaccharide (LPS) treatment methods and via the phagocytic
pathway using crocidolite asbestos. Keymacrophage­related surfacemarkers and cytokines
were analyzed: integrin alpha M (CD11b), integrin alpha X (CD11c), adhesion G protein­
coupled receptor E1 (F4/80), histocompatibility 2 class II (MHC II), interferon (IFN)­γ,
interleukin (IL)­1β, IL­6, tumor necrosis factor (TNF)­α, IL­10, IL­13, and IL­33.
4.3 Methods
4.3.1 Cell culture materials and methods
General methods for mouse BMdM macrophage and MGC culture, enrichment, and
quantification have been previously described by our laboratory (Chapter 2). Cells were
grown in a humidified, water jacketed incubator (Thermo Fisher Scientific, Waltham, MA)
at 37°C and 5% CO2. Sterile 0.2 μm filtered culture media consisted of RPMI­1640 with
10% heat­inactivated fetal bovine serum (FBS), 25 mM HEPES, 2 mM L­glutamine, 1
mM sodium pyruvate, 100 I.U./mL penicillin, and 100 μg/mL streptomycin (FBS: VWR
Seradigm, Radnor, PA; all others: Corning subsidiary Mediatech, Manassas, VA). Cells
were suspended by using 0.05% trypsin with 0.53 mM EDTA in HBSS (Corning) or
Accutase® with 0.5 mM EDTA in Dulbecco’s PBS (BioLegend, San Diego, CA), followed
by physical dislodging of cells as necessary using a cell scraper or pipette action. Treatment
concentrations of 30 ng/mL were used for recombinant murine proteins M­CSF (R& D
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Systems, Minneapolis, MN) and IL­4 (R& D Systems). Centrifugations of cells in tubes
were performed at RCFavg 300 x g for 5 min. Cytocentrifugations of cells onto slides were
performed at approximately RCFavg 250 x g for 5 min. Cell counting was completed using
a Beckman Coulter (Indianapolis, IN) Z2 cell counter.
Permanox is a trademarked (Nalge Nunc International, Rochester, NY)
polymethylpentene tissue culture­treated growth surface with a silicone gasket connecting
removable polystyrene chamber walls. Media working volumes per well or vessel were as
follows: 8­chamber permanox slides at 0.4 mL, 96­well tissue culture­treated polystyrene
(TCPS) plates (Greiner Bio­One, Monroe, NC) at 0.1 mL, and T75 TCPS flasks at 20 mL.
4.3.2 Mice
C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) aged 10 to 13 weeks were used for
all experiments. Mice were housed in microisolator cages with ad libitum access to food
and water in a specific­pathogen­free facility maintained at 22 ± 2°C, 30–40% humidity,
and 12­hour light/12­hour dark cycle. Mice were euthanized by intraperitoneal injection
of sodium pentobarbital followed by a secondary mechanical means of euthanasia prior
to removal of rear legs for bone marrow isolation in a tissue culture hood. Experimental
protocols were approved by the University of Montana Institutional Animal Care and Use
Committee.
4.3.3 Particle preparation
Asbestos was selected as a model treatment because it is well­established by our laboratory
and others to be a stimulator of macrophage activity in rodents and humans. Crocidolite
asbestos (diameter 160nm, length 5 μm) was obtained from Research Triangle Institute
(Research Triangle Park, NC). Asbestos was prepared into a homogenous dispersion
in phosphate­buffered saline (PBS, pH 7.4) immediately prior to in vitro exposure by
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sonicating for one minute with a 500W, 20 kHz Qsonica Q500 (Newtown, CT) cup­horn
system at 30% amplitude pulse.
4.3.4 Macrophage and MGC culture
BM was flushed from the tibiae and femora in a sterile environment, pooled, centrifuged,
resuspended in media, and seeded at 4 x 105 cells/cm2 in a T75 flask. Cells were incubated
at 37°C overnight. Adherent stromal cells were discarded, and suspended macrophage
progenitor cells were collected. Progenitor cells were added to T75 flasks at 2 x 105
cells/cm2 with M­CSF for four days to mature into BMdM. Mature BMdM were collected
using trypsin and were seeded at 9 x 105 cells/cm2 in permanox chamber slides with IL­4 for
four days. Media was replaced with fresh media containing IL­4, then cells were cultured
for five more days. The culture now consisted of a mixture of BMdM macrophages and
MGC.
Cell detachment was completed using Accutase instead of trypsin for the remainder of
the experiment, with efforts to handle cells gently to better preserve cell surface protein
integrity. The suspended macrophage and MGC mixture was transferred onto a pre­rinsed
20 μm cell strainer (PluriStrainer by PluriSelect; Leipzig, Germany) and washed twice
with 4 mL/wash into a tube. The strainer was inverted and washed twice with 4 mL/wash
into a new tube. Cells small enough to pass through the strainer into the first tube were
designated as the macrophage­enriched population, while cells blocked by the strainer
were designated as the MGC­enriched population. A sample of cells was used to confirm
enrichment. Remaining cells were seeded at 2.5 x 105 nuclei/mL (≈7.8 x 104 nuclei/cm2)
in a 96­well plate. Specified wells were treated with 20 ng/mL LPS from Escherichia coli
(MilliporeSigma) and 25 μg/mL asbestos. After 24 hours, cells were prepared for flow
cytometry and supernatants were collected for multiplex immunoassay.
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4.3.5 Quantification of microfiltration enrichment
Samples of macrophage­enriched and MGC­enriched populations were cytocentrifuged
and stained using a method similar to Wright­Giemsa (PROTOCOL™ Hema 3™; Fisher
Scientific, Kalamazoo, MI) by submerging slides in a methanol­based fixative for 90 sec,
“Solution I” for 120 sec, “Solution II” for 30 sec, and water for 90 sec. At least five random,
independent (non­overlapping) images were acquired per sample using a Zeiss Axioskop
upright microscopewith AxioCamMR3 camera (Carl Zeiss, Jena, Germany) at 100xmagni­
fication. MGC were defined morphologically as containing three or more nuclei within a
common cytoplasm. MGCquantification results are expressed as percent fusion by dividing
the number of nuclei within MGC by the total macrophage and MGC nuclei, then multi­
plying by 100. Alternatively, a purity index was calculated by dividing the number of MGC
by total cells.
4.3.6 Flow cytometry
Combined live macrophage and MGC cells were stained with HCS NuclearMask Blue
according to manufacturer (Thermo) recommendations. Antibody staining was performed
in 100 μl buffer consisting of 1% w/v bovine serum albumin and 0.1% w/v sodium azide
in PBS, sterile­filtered. Anti­mouse CD16/CD32 (Tonbo Biosciences, San Diego, CA) was
added at 5 μg/mL for 10 minutes to block non­specific antibody binding. The following
is a list of fluorochrome conjugated anti­mouse monoclonal antibodies obtained from
BioLegend, staining concentrations (μg/mL), and correspondingwavelengths (nm) of lasers
and filters: APCCD11b cloneM1/70 at 2.5 (637, 670/14), PerCP/Cy5.5 CD11c clone N418
at 10 (488, 695/40), PE F4/80 clone BM8 at 10 (561, 585/16), and FITC MHC II (I­A/I­E)
clone M5/114.15.2 at 2.5 (488, 530/30). Wavelengths for NuclearMask were 405, 440/50.
Laser power was 100 mW for 637 nm and 50 mW for others. Cell staining time was 20
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minutes, followed by two washes. Controls included unstained cells, cells with Nucle­
arMask only, fluorescence minus one, and antibody­capture beads (Thermo) for multi­
color compensation. At least 10,000 events per sample were analyzed using an Attune NxT
(Thermo) flow cytometer with v2.6 software, with further analysis using FlowJo v10.4.2
software. Note that this acoustic­assisted hydrodynamic focusing cytometer had a configu­
ration that accommodated large MGC cells, while other cytometers with small nozzles may
clog.
Forward and side scatter gating was used to remove debris. Macrophages and MGC
were separated according to nuclear fluorescence using methods described previously in
our laboratory (Chapter 2), which is similar to methods used for analysis of osteoclasts
[267] and megakaryocytes [268]. Preliminary experiments indicated that cells could be
gated into categories of one nucleus (1N), two nuclei (2N), or three or more nuclei (≥3N)
according to nuclear fluorescence, without the need for pre­enrichment by microfiltration.
Therefore, MGC and macrophages were combined during staining to improve consistency.
Flow cytometry data normalizationwas completed based on each individual event (e.g. cell)
by dividing surface protein fluorescence by nuclear fluorescence. The median normalized
ratio of all events within a sample was then used for graphing and statistical analysis.
4.3.7 Multiplex immunoassay
Cytokines secreted by macrophages and MGC were measured using a custom mouse U­
PLEXBiomarker Group 1 kit (Meso Scale Discovery, Rockville, MD), which is a multiplex
sandwich immunoassay consisting of biotinylated capture antibodies and SULFO­TAG
conjugated detection antibodies. The 96­well plate assay was completed according to
manufacturer protocol. The plate was washed with 300 μl/well using a ThermoWellwash 4
MK 2 and shaken at approximately 715 RPM on a Thermo 4625 shaker. Electrochemilumi­
nescence was measured using theMESOQuickPlex SQ 120 with DiscoveryWorkbench 4.0
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software. Secreted protein concentrations were calculated using a four­parameter logistic
standard curve. Some concentrations were below the limit of detection and could not be
estimated from the curves, particularly in unstimulated cells. These nondetect values were
considered to be zero for graphing and statistical analysis.
4.3.8 Statistics
Statistical analysis involved comparison of means using a two­way ANOVA followed by
multiple comparisons using Tukey’s honest significant difference (HSD) test to compensate
for increased type I error. Statistical significance was defined as a probability of type I
error occurring at less than 5%. Significant simple contrasts of predetermined scientific
interest are displayed on graphs, including treatment differences for each cell type and cell
type differences for each treatment; complex and cross­group contrasts are not shown (e.g.
Mac with LPS versus MGC control). Significant treatment differences compared to control
of corresponding cell type are shown as *p < 0.05, **p < 0.01, and ***p < 0.001. The
same p­value scheme is used for other contrasts indicated by daggers (†) with bars. Data is
represented as the mean ± standard error of three independent replicate groups of mice for
each condition. All analysis was completed in R v3.6.1 statistical software.
4.4 Results
4.4.1 Enrichment by microfiltration
Mature mouse BMdM were treated with IL­4 to induce macrophage fusion into MGC.
Then, the mixed culture was separated into macrophage­enriched and MGC­enriched
populations by microfiltration, as previously described (Chapter 2). A portion of these
cells were collected for cytocentrifugation, staining, and morphological assessment of
enrichment efficiency (Fig. 16). The percent fusion of each population was 33.1% for
78
MGC­enriched and 0.5% for macrophage­enriched. The purity index was increased 71­
fold. Remaining cells from each population were seeded according to number of nuclei/well
for subsequent experiments. Two groups of these cells received treatments known to
stimulate macrophages: LPS and a combination of LPS and crocidolite asbestos. Super­
natants containing secreted cytokines were collected after 24 hours and cells were prepared
for flow cytometry.
4.4.2 Surface markers
Surface proteins onmacrophages andMGCwere analyzed by flow cytometry 24 hours after
stimulation with LPS and asbestos. In order to compare marker expression between these
two cell types, data normalizationwas required due to the difference in cell size. To illustrate
the importance of normalization, cells were gated into categories of one nucleus (1N), two
nuclei (2N), or three or more nuclei (≥3N) for comparisons. The increase in surface marker
fluorescence correlates with an increase in the number of nuclei (Fig. 17). MGC are formed
by the fusion of macrophages into a larger cell, so it is logical that the nucleus to membrane
ratio remains proportional (Fig. 18). Evidence of this has been shown by live cell imaging
of fusion [235] and results suggesting similar buoyant densities (Chapter 2). Therefore,
surface protein fluorescence was normalized according to nuclear fluorescence of each
individual cell.
Normalized surface marker expression in macrophages and MGC was compared for
unstimulated cells, stimulated with LPS, and stimulated with LPS and asbestos (Fig. 19).
Results of a two­way ANOVA indicate that cell­type effects were not significant. Treatment
with LPS resulted in significant increases in F4/80 and a slightly increasing trend in CD11b
and CD11c, consistent with previous BMdM studies [269, 270]. Macrophage activation by
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A B
Fig. 16. Enrichment by microfiltration. Representative images of purified cell
populations resulting from microfiltration separation. (A) Cells that passed through the
filter were macrophage­enriched. (B) Cells blocked by the filter wereMGC­enriched. After
filtration, cell concentrations were adjusted to seed 96­well plates with equal numbers of






























































Fig. 17. Surface markers before normalization. Cells were gated according to nuclear
fluorescence into three groups: one nucleus (1N; black bars), two nuclei (2N; gray), and
three or more nuclei (≥3N; white). Median fluorescence intensity (MFI) of all surface
markers increases in binucleated macrophages (2N) and MGC (≥3N), which may lead to
the conclusion that marker expression is increased in these cells. However, the increase
in fluorescence may simply be a result of larger cell size, with actual membrane density




Fig. 18. Surface marker density illustration. Yellow rectangles indicate x number of
surface markers. If x markers on each single­nucleated macrophage were conserved during
fusion, then binucleated macrophages would each have 2x and an MGC with four nuclei
would have 4x. This may lead to a false interpretation that surface marker expression is
increased inMGC, when the actual membrane density distribution is equivalent. Therefore,
data should be normalized in proportion to the number of nuclei per cell.
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particle exposure has been shown to increase antigen­presentation [6], so LPS and asbestos
treatment results showing increased MHC II were expected, though the increase was not
statistically significant.
4.4.3 Cytokine secretion
Cytokines secreted by enriched populations of macrophages and MGC were analyzed by
multiplex immunoassay 24 hours after stimulation with LPS and asbestos. In contrast to
surface marker data, cytokine results did not require normalization because this was already
controlled by the experimental design: supernatants were collected from cells seeded at
an equal number of nuclei per well with an equal volume of media per well. Baseline
secretion of all cytokines was very low (Fig. 20), as expected. This is why it was important
to include treatments known to stimulate macrophages. Results of a two­way ANOVA
indicate that cell­type effects were significant (p<0.05) for all proteins analyzed. Therefore,
MGC in this study have an impaired ability to either produce or secrete these cytokines
compared to macrophages. Although certain cytokines secreted by stimulated MGC were
slightly increased from baseline, only IL­6 from the LPS­treated group showed a statis­
tically significant increase.
Macrophages secreted higher concentrations of multiple cytokines when stimulated
compared to baseline macrophages (Fig. 20). Many increases resulted from LPS treatment
alone, but other cytokines were further increased when asbestos was added. Particularly,
IL­1β and TNF­α were significantly higher in the LPS plus asbestos group compared to LPS
alone, consistent with our previous studies [271, 272]. It was anticipated that IL­6 would
also be increased by asbestos, but levels remained the same as with LPS alone. This was




























































































Fig. 19. Surface markers after normalization. Normalized protein expression by
macrophages (gray bars) and MGC (white bars) that were unstimulated (control) or
stimulated with LPS or LPS plus asbestos for 24 h. No significant differences in surface
markers were observed between macrophages and MGC. Asterisks(*) indicate significant










































































































Fig. 20. Cytokine secretion. Supernatant protein concentrations from enriched populations
of macrophages (gray bars) and MGC (white bars) that were unstimulated (control) or
stimulated with LPS or LPS plus asbestos for 24 h. The immunoassay included cytokines
generally associated with classical (M1; left column) and alternative (M2; right column)
activation. Asterisks(*) indicate significant treatment effects versus corresponding cell­
type control. Daggers(†) indicate other significant contrasts as shown by bars.
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4.5 Discussion
Our recent investigation of in vitroMGC formation (Chapter 2) helped establish techniques
that facilitated the completion of this study. Mouse BMdM were treated with IL­4 in
permanox chamber slides to induce macrophage fusion into MGC. In order to effectively
compare macrophages and MGC, it was important to purify populations arising from
the same original culture. Purity was increased 71­fold by simple microfiltration, which
allowed for continuation of the cell culture without stains or other treatments that would
interfere with remaining experiments. Additional purification steps may have improved
purity, but at the sacrifice of reduced total cell numbers. Enrichment allowed for more
appropriate phenotype comparisons betweenmacrophages andMGC. Themain objective of
this study was to assess common surface markers and cytokines at baseline and in response
to stimulation. Stimulation was especially important for meaningful cytokine comparisons
because both macrophage and MGC baseline secretions are very low.
Previous MGC phenotype studies [263, 265] used IL­4 to stimulate macrophage fusion
into MGC, then compared these cultures with untreated macrophages. Results from using
this experimental design cannot be used to distinguish whether any observed cell­type
differences were a consequence of multinucleation or an artifact of IL­4 treatment. In
the current study, enrichment methods allowed for macrophages and MGC to be sourced
from the same IL­4­stimulated culture. Cell culture could be continued after enrichment
by microfiltration without interfering factors present in other separation methods, such as
stains required for fluorescence­activated cell sorting. This is the first MGC phenotype
study, to our knowledge, that is controlled in a manner that removes confounding effects of
treatment differences and other manipulations.
Normalized surface marker expression results indicate that common macrophage
markers are present in a similar density on MGC. This was not surprising considering that
MGC are formed by macrophage fusion and both cell types were sourced from the same
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cultures. A particularly interesting result was that MGC­enriched cultures had a similar
response to stimulation as macrophage­enriched cultures. For example, MGC had the
capacity to respond to LPS by upregulating F4/80. This suggests that MGC have similar
levels of toll­like receptor (TLR) 4 and functional LPS­TLR4 signaling pathways.
Baseline cytokine secretion was very low in both macrophages and MGC, as expected.
However, the observation that MGC have a diminished ability to produce/secrete cytokines
in response to stimulation was somewhat unexpected. Surface marker results suggested that
MGC retain the capacity of reacting to LPS stimulation, indicating that those intracellular
signaling pathways were not impaired. However, it is possible that those surface proteins
were already loaded in intracellular vesicle pools, transferred from macrophages during
fusion, that translocated to the plasma membrane during stimulation. Increased cytokine
secretion is more dependent on de novo synthesis, followed by secretion via exocytosis.
Notably, release of cytokines from both conventional and unconventional (e.g. IL­1β after
LPS+Asb) secretion pathways were impaired in MGC.
One potential explanation of the impaired cytokine response in MGC is that the
presence of multiple nuclei disrupts intracellular signaling and transcription factor local­
ization. The organelle organization and nuclear coordination following fusion is not well
understood. An osteoclast study claimed that only certain nuclei within the multinucleated
cell are transcriptionally active [273], but another study said all nuclei were active [274].
Numerous cell functions could become disrupted throughout the complex pathway from cell
signaling in response to stimulation to transcriptional upregulation, protein processing, and
secretion. Further investigation is needed to determine how these mechanisms are altered
in MGC. Some example approaches include flow cytometry to assess relevant membrane
receptors, microscopic observation of transcription factor localization with nuclei, RT­
qPCR, immunoassays using cell lysates, and fluorescence microscopy of organelles and
secretory vesicles.
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Overall, MGC appear to maintain certain macrophage surface protein characteristics,
while losing the ability to promote an inflammatory response. These results fit with the
theory that MGC form a “wall” to isolate the host from a foreign body without causing
excessive inflammation. In this case, the presence of MGC would be beneficial. However,
more research is needed to better understand how the MGC phenotype may differ in
response to other stimulants and according to their environment. This fundamental cell
biology knowledge will help to develop methods to control the foreign body response, as
well as provide insight into several other granulomatous conditions in which the role of
MGC is unclear.
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